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Researchers have conducted multiple studies regarding opioid users, opioid addicts, 
relatives of addicts, and health professional responses. The opioid crisis has been a focus 
for scholars following the first wave of prescription in 1991 (CDC, 2016).  However, 
there is limited research that examines the lived experiences of law enforcement officers 
and their roles during an opioid overdose.  As the opioid crisis has continued to 
negatively affect individuals, families, communities, cities, and countries, federal, state, 
and local policymakers have searched for ways to combat the opioid crisis. For many law 
enforcement agencies, policymakers have enacted policy that mandates patrol officers 
carry and administer Narcan/naloxone. This qualitative phenomenological study 
examined the lived experiences of police officers who are mandated to carry and employ 
Narcan/naloxone during a perceived opioid overdose.  To gain a better understanding of 
how law enforcement officers perceive the requirement that seemingly changes their role 
from law enforcement to an emergency medical technician (EMT).  The research design 
for this study was Colaizzi’s descriptive phenomenological method with thematic-based 
analysis.  While each participant expressed their own experiences individually, four 
major themes (duty to serve, saving life, job hazard, and frustration) emerged.  The 
findings from this study can help law enforcement officials and policymakers further 
understand their officers’ perceptions of the harm reduction process related to the opioid 
crisis.  Additionally, these findings could lead to positive social change by making the 
law enforcement officers and community members’ stakeholders in developing positive 
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Chapter 1: Introduction to the Study 
In America, lethal drug overdoses claimed the lives of 52,404 people in 2015 
(American Society of Addiction Medicine, 2016; NIDA, 2017; Rudd et al., 2016). 20,101 
were attributed to prescription pain relievers, and 12,990 were related to heroin 
(American Society of Addiction Medicine, 2016; NIDA, 2017; Rudd et al., 2016). In 
2016, the number of lethal drug overdoses grew to 63,632 in one year. More specifically, 
opioids were found to be part of 42,249 of the overdose deaths, which is a significant 
increase from 2015 (American Society of Addiction Medicine, 2016; NIDA, 2017; Rudd 
et al., 2016). Scholars note the escalation can be attributed to the increase in synthetic 
opioid overdoses, which doubled between 2015 and 2016. A 2018 report showed 72,306 
overdose deaths in 2017 (National Emerging Threats Initiative, 2018). These deaths show 
an increase of 21% from 2016 data. Of the 72,306 fatal overdoses, nearly 68% involved 
opioids (National Emerging Threats Initiative, 2018).   
Between 2014 and 2018, in response to the growing concern of opioids, Alaska, 
Arizona, Florida, Maryland, Massachusetts, Pennsylvania, South Carolina, and Virginia 
have all declared a state of emergency in response to the epidemic (Rutkow & Vernick, 
2017). In Alabama, the number of overdose deaths including opioids climbed 82% from 
2006 to 2014 (Adams et al., 2016; Nelson et al., 2015; NIDA, 2017; Rudd et al., 2016; 
Young, 2016). In Jefferson County, Alabama, there were 436 accidental deaths in 2016; 
drug-related deaths accounted for nearly 55%, which is the most significant reported 
number since 2000 (Jefferson County Coroner-Medical Examiner's Office, 2017). 
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Data, dating back from 1999 to present, has shown a steady and substantial 
increase in the use of opioids and opioid-related deaths. With the constant rise in opioid 
use and the wide-reaching distress, experts and other involved parties are exploring the 
different possible responses available. During a White House press briefing, on October 
26, 2017, the President of the United States declared the opioid crisis a national public 
health emergency (Christie et al., 2017). Beyond the personal tragedy experienced by 
families and loved ones, the opioid crisis has had a significant impact on many state 
institutions, including hospitals, schools, prisons, and law enforcement. One initiative 
that has been both widespread and controversial is equipping law enforcement officers 
with the anti-opioid drug Narcan/naloxone (The White House, 2018; Christie et al., 
2017). In September 2016, the US Attorney General issued a memorandum stating a 
public health crisis in the opioid epidemic. The memorandum called for the use of 
naloxone as prevention. Since then, numerous law enforcement agencies across the 
country have implemented Narcan/naloxone programs (The White House, 2018; Christie 
et al., 2017).   
In response to the opioid crisis, Alabama state officials have tasked Jefferson 
County law enforcement with the intervention, which includes the use of Narcan 
(Naloxone; Alabama Department of Public Health, 2017; Birmingham Police, 2017; 
Jefferson County Sheriff, 2017). With this order, the various field officers in Jefferson 
County carry and are called upon to administer the opioid antidote Narcan when 
responding to individuals experiencing a possible opioid overdose (Alabama Department 
of Public Health, 2017; Birmingham Police, 2017; Jefferson County Sheriff, 2017). 
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Using law enforcement officers as a force multiplier increases the number of trained 
personnel able to respond during a possible opioid overdose. Law enforcement officers 
must negotiate between their duties to enforce the law on illegal drug trafficking and 
illicit narcotics use. Now, law enforcement officers take on their new role as an EMT, 
which has implications for their role according to social identity theory (Ashforth, 2016; 
White et al., 2002; Stets & Burke, 2000). The law enforcement officer social identity 
means they see things from the group perspective commonly shared by other law 
enforcement officer (Ashforth, 2016; White et al., 2016; Stets & Burke, 2000). The 
responsibility of administering Narcan/naloxone contrasts with their identity, due to this 
particular role switch (law enforcement officer to EMT), which puts pressure on the 
individual to control the surrounding environment outside of their usual social identity 
and skills (Ashforth, 2016; White et al., 2002; Stets & Burke, 2000). The expected switch 
from law enforcement officer to EMT makes the law enforcement officer vulnerable to 
attack from overdose victims becoming combative. The administering law enforcement 
officers must secure their weapon when dispensing the Narcan. If the victim becomes 
aggressive during this time, the law enforcement officer is defenseless, and there is 
potential his/her weapon can be taken and used against them by the overdosed combatant. 
Although there is a healthy amount of research into training medical-first 
responders witnessing an opioid overdose, I found no formal studies on law enforcement 
officers negotiating their responsibilities of guardian/protector and medical responder 
during opioid incidents as it relates to social identity. I conducted a qualitative, 
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phenomenological study to document the lived experiences law enforcement officers in 
Jefferson County, Alabama, face when responding to potential opioid incidents. 
Background 
Smith (2016) and Carter (2013) provided information on how identity shift can 
change behavior dependent on role or group shifting. Identity can define a person, and a 
significant life change can impact the identity of most people. Becoming part of a group 
may expose an individual to certain conforming behaviors, beliefs, and expectations with 
social support (Biddle, 1986). Police officers join a police organization with a 
commitment to integrate socially into the department for the best functional working 
environment. Social membership in a police organization is essential for an individual's 
self-esteem, and to stand in solidarity with their peer group is critical against any outside 
opposition that may harm a member of the group (Chattopadhyay & George, 2001). 
According to Chattopadhyay and George (2001), lower self-esteem and negative social 
identity may be associated with work-status dissimilarities between peer groups. 
Individuals may feel a loss of status and personal satisfaction when a critical role has 
changed (Biddle, 1986). For decades hospitals, medical service providers, and 
paramedics have been equipped and charged with administering anti opioid medications 
during apparent drug overdose incidents. With the shift in approach to drug use from 
prohibition and abstinence to harm reduction and social work philosophy, legislators 




As we have seen in the news, the consequences are tragic, nationally, in 2013, 
drug overdoses claimed more lives than traffic accidents (Adams et al., 2016; Nelson et 
al., 2015). Since 2000, the rate of deaths from drug overdoses has increased 137%, 
including a 200% increase in the rate of overdose death involving opioids (Adams et al., 
2016; Nelson et al., 2015). According to Hedegaard et al. (2017), the age-adjusted rate of 
drug overdose deaths in the United States has tripled from 6.1 per 100,000 standard 
population in 1999 to 19.8 in 2016. The Centers for Disease Control and Prevention 
(CDC) released provisional data for 2016, which reported 64,070 lethal drug overdoses in 
the United States from January 2016 to December 2016 (CDC, 2017). This data 
represents a 22% increase from the 52, 898 lethal drug overdoses reported in 2015 (CDC, 
2017). The perceived answer to these mounting issues is to equip law enforcement with 
naloxone (Narcan). 
In a summary report from The National Institute on Drug Abuse (2019), 
Alabama's drug overdose deaths increased 17.6% when comparing year totals from 2016 
(13.1 per 100,000) to 2018 (15.4 per 100,000; National Institute on Drug Abuse, 2019). 
Although the majority of drug overdose deaths in 2017 involved opioids, opioid overdose 
deaths are not included for the state, with 107.2 opioid prescriptions written for every 100 
persons (National Institute on Drug Abuse, 2019). No longer able to ignore these 
numbers, the US Department of Health and Human Services (HHS) initiated a survey of 
pain management clinics through a patient satisfaction survey (Adams et al., 2016; 
Nelson et al., 2015). The outcomes of this two year survey led the CDC to release new 
guidelines for prescribing opioids nationwide and continues to promote education on 
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chronic pain management and the risks of opioid use (Adams et al., 2016; Nelson et al., 
2015). With all of this, the opioid crisis continues to plague the country, and there has 
been a steady increase in opioid-related deaths in the United States. 
In April 2019, the Jefferson County Coroner/Medical Examiner's Office 
(JCCMEO), published a report noting there was a 15.2% decrease in the total drug deaths 
from 2017 (269 drug deaths) to 2018 (228 drug deaths; JCCMEO, 2019). Additionally, 
there was a 14.4% decrease in opioid deaths from 2017 (201 opioid deaths) to 2018 (68 
opioid deaths; JCCMEO, 2019). However, opioid deaths are still the leading factor in 
drug overdose deaths in Jefferson County, Alabama (JCCMEO, 2019). 
Statistics alone do not portray the devastating impact of the opioid epidemic on 
communities like Jefferson County, Alabama. Reading the firsthand experiences of law 
enforcement officers who deal with the victims, the grieving family members, and the 
addicts themselves will develop the whole picture of this epidemic. The opioid epidemic 
has continued to evolve from its beginning of nonmedical use of prescription medications 
to heroin to the synthetically produced products such as fentanyl. Even the sources of the 
drugs have evolved to include doctors in prescription pill-mills, neighbors, friends, 
foreign laboratories on the dark web, to teens who steal medications from the medicine 
cabinet. There is no discrimination in this fight; all backgrounds, education levels, and 
socioeconomic status' have and will continue to be affected. 
In 2019, the Drug Enforcement Administration (DEA) listed prescription opioids, 
heroin, and fentanyl as the principal drug-related threats to the United States. Although 
prescription opioids, heroin, and fentanyl may fall under a different schedule, they are 
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similar in composition (DEA, 2018; Rudd et al., 2016; Young, 2016). One could argue 
that drugs such as heroin and fentanyl are more illicit than prescription opioids such as 
oxycodone, hydrocodone, methadone, etc. However, the aftermath of abuse and overdose 
drives the need for naloxone. Naloxone is an opiate antidote that works to block the 
opioid receptors and effectively reverses an overdose for a limited period (CDC, 2018). 
As of November 1, 2013, all states and jurisdictions of the United States passed 
legislation that allowed paramedics to carry and administer naloxone. Most notably, in 
many jurisdictions, paramedics have been carrying and administering naloxone for 
decades. However, as the number of overdose cases continued to skyrocket, the need for 
expanded use of naloxone has been debated as an effective answer. In more rural areas of 
the country, law enforcement officers typically have a faster response time than their 
paramedical counterparts. With this in mind, this study seeks to examine the lived 
experiences of law enforcement officers in Jefferson County, Alabama, who are 
mandated to carry and administer Narcan (naloxone). As the opioid epidemic continues 
to plague the United States, police officials have received public backlash for their 
hesitation to equip their officers with naloxone. Currently, there has not been much 
research that has examined how law enforcement officers feel about this additional 
responsibility. 
The relevance of this study is two-fold; one, we are currently living through an 
opioid epidemic in which naloxone has become the "life-saving drug." Secondly, not all 
law enforcement agencies have embraced the legislation authorizing police to carry 
naloxone. Additionally, many agencies that have enacted the policy may be experiencing 
8 
 
difficulty in receiving and maintaining adequate funding opportunities to continue this 
policy. 
This study provided a firsthand account of the insights and perceptions of various 
law enforcement officers, who are required by their current policies to carry and 
administer Narcan (naloxone). This study aimed to identify how law enforcement officers 
and their day-to-day interactions were affected by the naloxone use policies. Conducting 
this study using the perceptions and insights of the frontline officers concerned offered a 
new analysis of this relevant topic.  This study's results can provide policymakers and 
police officials a greater understanding of the challenges and issues their frontline 
officers deal with day to day enacting the naloxone policies. 
Problem Statement 
The devastating effects of the opioid epidemic have resulted in several policy 
changes designed to address the growing number of related opioid overdoses better. No 
matter the right intentions, any of these changes have a ripple effect on the people subject 
to these changes. Identity is the characteristic of a person, wherein identification with a 
specific group of people can give strength and well-being to an individual (Belmi et al., 
2015). One of these policy changes directly affects the day-to-day roles and 
responsibilities of many law enforcement officers. The problem is that the patrol officers 
who are mandated to carry and employ Narcan/naloxone are now responding in a 
capacity more suited to that of an EMT then in law enforcement. 
  According to the North Carolina Harm Reduction Coalition (NCHRC), as of 
November 2018, 2,482 law enforcement agencies in the United States have enacted 
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naloxone policies (NCHRC, 2017). Most notably, this number only includes law 
enforcement agencies registered with the NCHRC. There is no reason to believe this 
number will not continue to increase as opioid use and the prevalence of overdoses 
continue to rise. With this rise is the possibility of a loss of identity. Loss of identity can 
often mean a loss of status and family with feelings of rejection and grief (Burns, 2015). 
As a medical procedure, administering naloxone is viewed by many as requiring 
those authorized to carry the product to receive training before equipment. Carter (2013) 
sought to understand how identity and behavior are influenced by environmental factors. 
Results indicated that moral identity influenced individual behavior when alone or in a 
group. Research is needed to examine the effects of the identity verification process in 
new social context situations (Carter, 2013). Since the inception of naloxone, paramedics 
have carried the product as part of their daily equipment. Some argue the naloxone 
policies that allow law enforcement officers to administer Narcan/naloxone represent a 
shift in their regular duties and responsibilities. For clarity, in recent years, naloxone has 
evolved to the current option, a nasal spray "Narcan," which is a less cumbersome option 
then the injectable naloxone. Nevertheless, with administering any medication, there are 
potential complications that may arise with using Narcan (naloxone).  To the public and 
some policymakers and police officials, these policies may seem necessary and even 
overdue. However, this research seeks to provide insight to all those involved with the 
naloxone policy, specifically the perceptions of law enforcement officers who are 
mandated to carry and administer naloxone.   
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In early 2015, Alabama state representative Allen Treadaway (former assistant 
chief of the Birmingham Police Department) proposed a bill to address the growing 
number of overdose deaths in the state (Alabama Legislative Services Agency, 2019). 
The bill would allow police officers, family members, and addicts to carry Narcan 
(naloxone) and legally administer it to a user who has overdosed (Alabama Legislative 
Services Agency, 2019).  Paramedics in Birmingham, Alabama have been equipped with 
Narcan/naloxone since the early 2000s; however, in rural parts of Jefferson County, law 
enforcement officers were able to respond quicker then paramedics and were often first 
on the scene. At this time, Alabama joined more than 30 US states to pass laws to 
increase access to naloxone. The proposed bill included a Good Samaritan clause 
designed to protect those who call the authorities in overdose cases. These people who 
are violating misdemeanor drug or underage drinking laws will not be arrested if they 
report an overdose and remain at the scene to help the victim (Alabama Legislative 
Services Agency, 2019). 
Purpose of the Study 
The purpose of the research was to gain an understanding of the law enforcement 
officer's perceptions of the mandated Narcan/naloxone policy as they negotiate the roles 
and responsibilities of both law enforcement officers and EMTs during a perceived 
opioid overdose. This study presented information regarding the lived experiences 





The following research question was used to address the identified gap in the 
literature and to address the stated problem: 
Research Question 1 (Qualitative): How do law enforcement officers, who are 
mandated by policy to carry and administer naloxone, perceive this policy change as it 
relates to their day-to-day work identity? 
Theoretical/Conceptual Framework 
The conceptual framework for this study is social identity theory which deals with 
intergroup relations and how people see themselves as a member of a group (i.e., law 
enforcement community) as compared to people not in the group and the consequences of 
this categorization (Ashforth, 2016; Hogg et al., 2002; Stets & Burke, 2000; Tajfel & 
Turner, 1979). Henri Tajfel and John Turner developed a social identity theory in 1979, 
which includes components of self-categorization, social identity, and social comparison. 
Tajfel and Turner (1979) proposed that the groups (e.g., police, EMT, fire dept., etc.) 
which people belong to be a valuable source of pride and self-esteem.  
Groups give us a sense of social identity and belonging. To increase our self-
image, we as individuals enhance the status of the group to which they belong.  We as 
individuals also increase our self-image by discriminating and holding prejudiced views 
against the group(s) to which we do not belong, the out-group. Through social 
categorization, we as individuals divide the world into "us" and "them," in-group being 
"us" and the out-group being "them" (Tajfel & Turner, 1979).  Using this theory, I 
examined the lived experiences of law enforcement officers in Jefferson County Alabama 
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who are asked to carry Narcan/naloxone as part of their patrol responsibilities, discussing 
their understanding of their identity within their organization and their role in response to 
possible opioid overdose (Birmingham Police, 2017; Jefferson County Sheriff, 2017). 
In contrast, an individual’s role means they act in a way to fulfill the duties and 
expectations assigned to the role, serving as an EMT although the individual is a law 
enforcement officer (Ashforth, 2016; White et al., 2002; Stets & Burke, 2000; Tajfel & 
Turner, 1979). The distinction between these two perspectives asserts social identity is a 
uniform perception and actions among in-group members (Ashforth, 2016; White et al., 
2002; Stets & Burke, 2000; Tajfel & Turner, 1979). The role of the officer resides in 
differences in perception and actions of the individual acting in a specific role (i.e., law 
enforcement officer/EMT) as it relates to counter-roles which require negotiation 
(Ashforth, 2016; White et al., 2002; Stets & Burke, 2000; Tajfel & Turner, 1979). This 
perception is particularly applicable in the discussion on equipping law enforcement 
officers with naloxone. This study aimed to develop a better understanding of law 
enforcement officers' perceptions of the use of Narcan (naloxone) in the field, as it is 
essential to differentiate between general law enforcement officers' views on naloxone 
itself, and their view of themselves as law enforcement officers. 
Nature of the Study 
This phenomenological study focused on the negotiation between roles law 
enforcement officers face when responding to possible opioid overdose.  This study's 
nature was qualitative with an interpretive phenomenological perspective, which sought 
to understand the meaning of experiences of a person or a group of individuals in context 
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to their daily work practices and socialization (Lopez & Willis, 2004; Moustakas, 1994; 
Van Manen, 2017). Phenomenology is a scientific method of inquiry understood through 
the investigation of individuals' personal experiences (Lopez & Willis, 2004; Moustakas, 
1994; Van Manen, 2017).  Employing social identity theory as it relates to the law 
enforcement officer who categorize, identify, and compare themselves as part of the 
group (Ashforth, 2016).  However, these officers, as mentioned earlier, must negotiate 
between roles of law enforcement and EMT, from an interpretive, phenomenological 
perspective (Ashforth, 2016; Creswell, 2014; Hatch, 2002; White et al., 2002; Moustakas, 
1994; Stets & Burke, 2000; Tajfel & Turner, 1979; Van Manen, 2017). Human science 
focuses on multiple aspects of phenomena including studying, defining, describing 
phenomena, and collecting associated information.  Any phenomena can be the starting 
point for a phenomenological study (Hatch, 2002; Moustakas, 1994; Tajfel & Turner, 
1979; Van Manen, 2017). 
Definitions 
Aftercare: Subsequent or follow up care (Adams et al., 2016). 
Analog: According to the Drug Enforcement Administration, "A controlled 
substance analog is a substance which is intended for human consumption and is 
structurally or pharmacologically substantially similar to or is represented as being 
similar to a Schedule I or Schedule II substance and is not an approved medication in the 
United States" (DEA, n.d.). 
Bitcoin: Bitcoin is a form of digital currency that allows the buyer to remain 
anonymous. Once bitcoin is acquired, it is stored in a digital wallet, housed in the cloud, 
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or on the owner's computer (Yellin, Aratari, & Paglieryet, n.d.). Bitcoin transactions are 
logged; however, the identity of the buyer and sellers are not released. Instead, the users 
are tracked solely by their digital wallet number. For this reason, bitcoin has become the 
primary currency for illicit transactions in the darknet marketplace. 
Canteen Culture: Sub-cultural police talk of the world when officers are away 
from management (Ainsworth, 2002). 
Civilian: An individual who is not a member of a particular group or profession 
like a police force (Ainsworth, 2002). 
Collective Identity: Group membership, commitment, and closeness to other 
group members; sharing behavioral characteristics (Dimitrova et al., 2014). 
Dark Web: Deep and dark web are used interchangeably; however, this is not 
accurate. Thompson (2015) defined the dark web as "Accessible, albeit anonymously 
hosted, websites that exist within the Deep Web." To access the dark web, the user must 
utilize software designed to mask the user's IP address. The onion browser, aka TOR, is a 
commonly used software (Thompson, 2015). 
Darknet Marketplace: Anonymous marketplace which facilitates the sale of 
potentially illicit materials (Thompson, 2015). The use of the dark web protects the 
identity of the seller and consumer. Silk Road is an example of a well-known illicit, dark 
web marketplace. 
Deep Web: The deep web is the section of the World Wide Web, which is not 
indexed by conventional search engines (Thompson, 2015). 
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Disengagement: The process of withdrawal or separation from a particular group 
(Tewksbury & Copenhaver, 2016). 
Diaspora: A social entity of individuals who identify with each other even when 
separated (Degli Esposti, 2017). 
Doctor Shopping: Doctor shopping refers to patients who see multiple doctors 
attempting to receive several prescriptions within a short time (Melville 2013). 
Specifically, an individual is considered to be "doctor shopping" when he/she sees five or 
more prescribers and visits five or more pharmacies in 90 days. This allows patients to 
fill multiple prescriptions at once, often for the same medications, unbeknownst to the 
providers. Prescription drug monitoring programs have helped physicians and 
pharmacists better monitor the actions of patients and therefore curtail the prevalence of 
doctor shopping. 
Drug Diversion: Drug diversion occurs when a legally prescribed control 
substance is transferred from the individual for whom the prescription is written to 
another individual, for an illicit purpose, such as use or sale (DEA, n.d.).  Drug diversion 
was prevalent during the "pill-mill era." Notably, the DEA employs countless "diversion 
investigators," a position designed solely to combat drug diversion. 
Harm Reduction: An umbrella term for interventions aiming to reduce the 
problematic effects of behaviors (Marlatt, 1998). 
Identity: The characteristic put forth by a person, wherein identification with a 




Identity Transition: A life change that forces adaptation to different life situations, 
like a change in employment status (Belmi et al., 2015). 
Life Course Perspective: Examination of life events using different variables 
(Bennett et al., 2016). 
Naloxone: Naloxone is an FDA approved medication used to prevent and reverse 
the effects of the opioid. Naloxone is typically administered when an individual is 
undergoing an opioid overdose. The medication blocks opioid receptors and can reverse 
the damage of the overdose (SAMHSA, 2016). 
Narcan: Narcan is a form of naloxone that is administered through the nasal 
cavity (SAMHSA, 2016). 
Over-identification: Extreme internalization; loss of identity within an 
organization (Galvin et al., 2015). 
Oxy Express: The nickname of the Florida highway system due to the prevalence 
of overdoses that occur while individuals were traveling to and from Florida with the sole 
purpose of acquiring OxyContin and other prescription drugs (Department of Justice, AG 
Remarks, 2011).  Florida's lax prescription laws and the absence of a PDMP (until 2011) 
appealed to non-Florida residents in the surrounding area, where regulations are more 
stringent. 
Pain Management Clinic: Health care clinics designed to detect, diagnose, and 
manage chronic pain (SAMHSA, 2016). 
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PDMP: A Prescription Drug Monitoring Program is a statewide database that 
collects data about the dispensing of certain substances. PDMP's are a resource used to 
combat prescription drug diversion and abuse (SAMHSA, 2016). 
Peritraumatic dissociation: A coping mechanism used to protect oneself in a 
traumatic situation (McCanlies et al., 2017). 
Pill Mill: The term "pill mill" is typically used to describe a health clinic, doctor, 
or pharmacy that irresponsibly and recklessly prescribes or dispenses controlled 
substances (Rigg et al., 2010). 
Pill Mill Legislation: In 2011, the Florida legislators passed the Anti-Pill Mill 
Bill, which put measures to address the pill mill issues in the state (Department of Justice, 
AG Remarks, 2011). 
Pluralistic ignorance: An individual's behavioral change following the perception 
of what other group members support (Karaffa & Koch, 2016). 
Psychological well-being: mental well-being (Asebedo & Seay, 2014). 
Relational Identification: Connections with members belonging to one's 
workgroup (Zhang et al., 2014). 
Resiliency: The ability to recover quickly (Adams et al., 2016). 
Role: in sociology, the behavior expected of an individual who occupies a given 
social position or status. A role is a general pattern of behavior that is socially 
recognized, providing a means of identifying and placing an individual in a society 
(Belmi et al., 2015).   
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Schedule of Controlled Substances: Drugs, substances, and certain chemicals used 
to make drugs are classified into five distinct categories or schedules depending upon the 
drug's acceptable medical use and the drug's abuse or dependency potential (DEA, n.d.). 
Schedule I drugs have no approved medical use and are deemed "extremely addictive", 
whereas Schedule V drugs represent the lowest potential for abuse (DEA, n.d.). 
Self-categorization: To perceive collections of people and define oneself as part 
of a particular social group (Dimitrova et al., 2014). 
Self-stigma: An individual's internal fear of rejection (Dimitrova et al., 2014). 
Social comparison: Determination of social and personal self-worth based on the 
perception of being like others (Lancee & Radl, 2012). 
Social Connectedness: Participation in social interactions with family, friends, 
community, and volunteering (Lancee & Radl, 2012). 
TOR: Software that allows access to the dark web (Thompson, 2015). 
Transition: The process of changing from one condition to another (Transition, 
n.d.). 
Work Centrality: The extent that an individual identifies with a work role 
(Armstrong-Stasson et al., 2012). 
Assumptions 
The following assumptions were made about the participants of this research 
study: (a) the participants cooperated fully throughout the study, (b) if at any time the 
participants no longer wished to participate in the interview, they would have informed 
me, (c) all participants were current/active law enforcement offices in Jefferson County, 
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Alabama, (d) all participants had firsthand experience with an opioid response, and (e) all 
participants had firsthand knowledge and experience with Narcan/naloxone. 
Scope and Delimitations 
The purpose of this study was not to measure the effectiveness of Narcan or 
Naloxone, nor to represent the experiences of all law enforcement officers who are 
required to carry antiopioid medications as part of their issued equipment. Only the 
experiences of the participants were represented. This study does not include individuals 
outside of Jefferson County, Alabama, who participate in similar intervention strategies 
or individuals who did not respond to the request for participants. 
Limitations 
The snowball method relied on people's willingness to forward their colleagues 
the invitation to participate in the study. Also, some law enforcement personnel were not 
willing take part in the study. Another limitation was the number of law enforcement 
officers compared to their level of experience on the force and experience with 
Narcan/naloxone. Additionally, participants were not randomly selected due to the 
critical need to utilize law enforcement officers with experience using Narcan/naloxone 
as well as officers who have responded to an opioid overdose. 
Yin (2017) defined a six-step process that may be utilized when conducting a 
qualitative case study. The first step is defined as the "planning stage." During this time, I 
conducted a literature review and identified the notable gaps. I utilized research questions 
that served to address the topics (Darke et al., 1998). In this instance, I was able to 
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examine the opioid epidemic as a whole. I examined the ever-changing epidemic, the 
current climate at the time, and the role of law enforcement officers. 
Although there was current research on the topic, there was ample detail to 
address changing policies and additional applicable statistics. The growing number of 
statistics and the changing policies demonstrate how these changes can affect the 
community. However, the research had not examined the thoughts and opinions of the 
law enforcement officers in Jefferson County, Alabama. This literature review was 
conducted to fill the gap in the research. 
Significance 
Law enforcement officers' primary tasks are crime prevention, emergency 
response, and providing support services (Birmingham Police, 2017; Criminal Justice 
USA, 2018; Jefferson County Sheriff, 2017). The upward trend in opioid overdose deaths 
has lead Alabama state officials to include the antiopioid drug Narcan (Naloxone) as part 
of Jefferson County law enforcement officers' routine patrol equipment (Alabama 
Department of Public Health, 2017; Birmingham Police, 2017; Jefferson County Sheriff, 
2017). With this additional responsibility, law enforcement officers have to negotiate its 
role between law enforcement officer and EMT providers. The proposed study seeks to 
provide pertinent information regarding the lived experiences law enforcement officers in 
Jefferson County, Alabama, tasked with responding to possible opioid overdose, face as 
they negotiate their dual roles. 
This executive decision to require officers to administer Narcan/naloxone 
significantly alters the prototypical duties and responsibilities of law enforcement 
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officers. However, at the time, little research had been conducted on the perceptions of 
law enforcement officers concerning the new expectation and alteration in their duties 
and responsibilities. This study aimed to bridge the gap in the research and develop a 
better understanding of how law enforcement officers feel about this added responsibility 
and the new role they are expected to fill in the war on drugs. In light of the constant 
coverage of the opioid crisis, the topic was both timely and relevant. Additionally, this 
provides those officers an outlet to voice their opinions on this controversial topic. 
Summary 
This research aimed to identify and further examine the lived experiences of law 
enforcement officers regarding policies that require the officer to carry and administer 
naloxone. Additionally, this research was designed to fill the gap in research which failed 
to address the ever-evolving role of law enforcement officers in the continuing battle 
against opioids. This research can provide policymakers, politicians, law enforcement 
officials, and other consumers' overdue data which can aid high-level discussions 
regarding the role of law enforcement in the opioid epidemic. Ideally, this research will 
allow law enforcement officers to provide accurate and meaningful data that can help 
guide future policy decisions. 
In 1995, Purdue Pharma issued the "Extended-release" version of OxyContin. 
Twelve years later, in 2007, the federal government criminally prosecuted Purdue 
Pharma for misleading consumers on the addition-potential of OxyContin, among other 
charges. In 2011, Florida began cracking down on pill mills through legislation and the 
inception of the PDMP. Through all of this, the law enforcement community was charged 
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with combatting the opioid epidemic from a police perspective (Ainsworth, 2002; 
Lawson, 2014). The current approach has shifted law enforcement expectations, which 
potentially creates an "us versus them" mentality for police officers in the media and 
community (Ainsworth, 2002; Lawson, 2014).  There are zero arguments that there are 
various efforts designed to combat the opioid epidemic; however, through the desperation 
associated with this growing epidemic, law enforcement officers have seen a shift in their 
responsibilities. Officers who were once instructed to crack down on drug use are now 
expected to carry and administer an opioid reversing medication.  Additionally, Good 
Samaritan legislation generally prevents officers from charging drug users using illicit 
paraphernalia identified when responding to an overdose episode (Davis, 2017). This 
research aimed to address the unheard voice of law enforcement officers on the frontline 




Chapter 2: Literature Review 
This literature review sought to develop a better picture of the daily lives of law 
enforcement officers who are dealing with the current opioid epidemic. The purpose of 
the research was to examine the lived experiences of law enforcement officers in 
Jefferson County. They are tasked to negotiate the roles and responsibilities of both law 
enforcement officer and EMT as they are tasked to administer Narcan (Naloxone) during 
a possible opioid overdose. During a potentially hostile situation, EMT personnel are 
trained to wait for the police before entering the incident scene. When law enforcement 
officer arrives on a possible opioid overdose scene, they are expected to react to the 
unfolding events without hesitation, which could require Narcan (Birmingham Police, 
2017; Jefferson County Sheriff, 2017). During a response, the law enforcement officer 
on-scene is expected to switch from their natural state (social identity) as 
guardian/protector to their assigned role as a medical first responder, during this time 
they are vulnerable (Ashforth, 2016; Heaven et al., 2013; White et al., 2002; Stets & 
Burke, 2000). This study looked to present information regarding the lived experiences 
Jefferson County law enforcement officer faces during an opioid overdose. 
Literature Search Strategy 
The goal of this literature review was to identify pertinent articles, journals, and 
dissertations related to an individuals' identity. In order to conduct a comprehensive 
review of the literature, numerous databases were used. The literature's initial search was 
limited to the previous five year period (2014 – 2019). The search was extended to 
beyond five years in order to develop more depth on the topic. This extension was due to 
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limitations in the number of resources available to support the research question. The 
selected articles were seminal, which establishes credibility and foundation for the study. 
The discovery of solid material included searching the local library and searching the 
following databases: ProQuest, EBSCO, JSTOR, National Criminal Justice Reference 
Service, and Sage Online. Additionally, Google Scholar and attending seminars on the 
growing opioid epidemic were used as sources. The initial search terms included 
addiction, fentanyl, heroin, naloxone, Narcan, opioid, and prescription pill. These terms 
were cross-referenced with addiction, epidemic, law enforcement, morality, and overdose. 
The studies and information that fit the criteria for the literature review were sorted based 
on the topic of the study. The articles selected were an amalgamation of various sources, 
all focused on individual identity, law enforcement officers, and the opioid epidemic. The 
relevant articles were categorized by topic and organized by date. Sorting by date allowed 
me to focus on the most recent reports.  
This literature review included a variety of different studies, including 
quantitative, qualitative, and mixed methods.  Additionally, due to the topic at hand, a 
significant amount of the research was published by government entities. The literature 
review is broken up into three sections. The first section discusses social identity theory, 
the second section looks at the opioid epidemic as a whole, and the transition from licit to 
illicit opioids. The third section presents the topic of naloxone. 
Theoretical Foundation 
Individuals strive to become unique to others, unique to a specific role, or 
exclusive to social identity (Ashforth, 2016; Heaven et al., 2013; White et al., 2002; Stets 
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& Burke, 2000). Based on this theory, social identity theory deals with intergroup 
relations and how people see themselves as a member of a group (i.e., law enforcement 
community) as compared to people not in the group and the consequences of this 
categorization (Ashforth, 2016; Heaven et al., 2013; White et al., 2002; Stets & Burke, 
2000).   
An individual’s particular social identity means they are with a specific group (in-
group), which means they view themselves as they see others who are also part of the in-
group e.g. law enforcement community (Ashforth, 2016; Heaven et al., 2013; White et 
al., 2002; Stets & Burke, 2000).  Becoming part of a particular group leads to self-
categorization and social comparison, both having different consequences (Ashforth, 
2016; Heaven et al., 2013; White et al., 2002; Stets & Burke, 2000).    
The consequence of self-categorization and social comparison establishes a 
heightened sense of in-group similarities as well as a heightened sense of differences 
from those viewed as out-group members (Ashforth, 2016 Heaven et al., 2013; White et 
al., 2002; Stets & Burke, 2000). The differentiation of in-group members from out-group 
members exceeds superficial constructs and effect all attitudes, beliefs, values, reactions 
and behavioral norms as well as style of speech (Ashforth, 2016;  Heaven et al., 2013; 
White et al., 2002; Stets & Burke, 2000). Another consequence of self-categorization and 
social comparison is the impact to the individuals' self-esteem as it relates to the in-group 
and whether they are judged positively or negatively (Ashforth, 2016; Heaven et al., 
2013; White et al., 2002; Stets & Burke, 2000).   
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Self-categorization and social comparison are key to how the individual sees 
thEMTelves in structured society and only exists concerning contrasting categories (i.e., 
Law Enforcement Officers vs. Emergency Medical Technicians); each group having 
more or less power, prestige, or status (Ashforth, 2016; Heaven et al., 2013; White et al., 
2002; Stets & Burke, 2000). Social identity theory seeks to address the behaviors of 
individuals who categorize themselves as part of an in-group to experience positive 
emotions (Smith, 2016). This association answers the question of "who am I" and thus 
has a direct impact on the individuals' level of connectedness, empowerment, and sense 
of meaning (Ashforth, 2016; White et al., 2002; Smith, 2016; Stets & Burke, 2000). 
Social identity theory was first introduced in 1979 and included components of 
self-categorization, social identification, and social comparison (Ashforth, 2016; Smith, 
2016). The suggestion is individuals seek to enhance their self-esteem, self-pride, and a 
positive self-image by becoming a member of a specific group, which is seen as superior 
to other groups (Ashforth, 2016; Smith, 2016). This belief can affect the law enforcement 
officer’s view as it relates to non-police duties (out-groups) and leads to feelings of loss 
of importance when required to complete nonpolice assignments. From the perspective of 
the law enforcement officer, an individuals' social identity is not solely related to the 
parent group (law enforcement officers), but also the underlying in-groups such as their 
specific group location, department, shift, etc. (Ashforth, 2016; Heaven et al., 2013; 
White et al., 2002; Stets & Burke, 2000). Additionally, members of the in-group view a 
situation from that group's perspective; for example, to serve and protect, enforce the law, 




The proposed study examined the lived experiences of law enforcement officers 
who are asked to carry Narcan as part of their patrol responsibilities. Discussing their 
understanding of their identity within their organization and their role in response to 
possible opioid overdose (Birmingham Police, 2017; Jefferson County Sheriff, 2017). In 
contrast, one's role means they act in a way to fulfill the duties and expectations assigned 
to the role, serving as an EMT provider although you are a law enforcement officer 
(Ashforth, 2016; Heaven et al., 2013; White et al., 2002; Stets & Burke, 2000). The 
distinction in these two perspectives asserts social identity is a uniform perception and 
actions among in-group members (Ashforth, 2016; Heaven et al., 2013; White et al., 
2002; Stets & Burke, 2000). An individual's role resides in differences in perception and 
actions of the individual acting in a specific role (i.e., Law Enforcement Officer/EMT 
provider) as it relates to counter-roles which require negotiation (Ashforth, 2016; Heaven 
et al., 2013; White et al., 2002; Stets & Burke, 2000). 
Social Identification 
Social identification (social identity) is the definition of oneself within a group 
affiliation; this can include a role-specific group such as a law enforcement officer 
(Ashforth, 2016; Smith, 2016). An individual can gain self-knowledge through 
organizational affiliation, i.e., law enforcement officer can identify with their 
organization/department (Ashforth, 2016; Smith, 2016). An unsatisfactory transition out 
of a role or workplace can occur with a perceived loss of organizational affiliation and 
confuse the individual's social identity (Ashforth, 2016; Smith, 2016). Operating in a 
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capacity outside of viewed roles can shift identity. SIT can show how identity is affected 
when law enforcement officer duties transition to those of EMT. 
Identity 
Brown (2015) noted an individuals' identity is connected to their past, present, 
and future projected self. An individual's total identity is made up of the self, social 
relations, and occupational combination and is tied to emotions (Brown, 2015; Conroy & 
O'Leary-Kelly, 2014; Lawson, 2014). An individuals' positive-identity is associated with 
good self-esteem and strong resilience (Brown, 2015; Conroy & O'Leary-Kelly, 2014; 
Lawson, 2014). An individual's identity can be determined based on their view of a 
situationally appropriate image of behavioral expectations (Brown, 2015; Conroy & 
O'Leary-Kelly, 2014; Lawson, 2014). Brown (2015) suggests identity is made up of 
evolved meanings that the individual attaches to themselves through personal awareness 
of identity formation and social interaction. This personal identity can be created and 
maintained through activities that support that specific identity (Brown, 2015; Conroy & 
O'Leary-Kelly, 2014; Lawson, 2014). An individual's identity can be composed of 
emotionally charged processes, and these emotionally charged identities can occur 
through the work identity of law enforcement officers, which leads to a sense of stability 
(Brown, 2015; Conroy & O'Leary-Kelly, 2014; Lawson, 2014). 
Recruits to an organization are looking to identify. They are influenced by 
seasoned members to conform to their new social norms and develop a negative view of 
others i.e., out-group (Ainsworth, 2002: Brown, 2015). However, this identity can be lost 
immediately with a career change or role transition (Brown, 2015; Conroy & O'Leary-
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Kelly, 2014; Lawson, 2014). Law enforcement officers' physical identity is readily 
observed when they are in uniform. When the law enforcement officer wears their badge, 
duty belt, and sidearm, their social identity is immediately associated with similar 
situations and group membership (Brown, 2015; Conroy & O'Leary-Kelly, 2014; 
Lawson, 2014). Threats to an individual's group identity devalue one's group, due to 
negative stereotyping, which can affect work attitude and performance (Belimi et al., 
2015). 
Collective Identity 
An essential part of individual identity is group membership, which 
depersonalizes an individual with collective identification to work together cohesively for 
group success (Zhang et al., 2015). Collective identity is self-perceived social 
membership and commitment with a symbolic group (Dimitrova et al., 2014; Miscenko 
& Day, 2015). This ideal includes an attachment, the group's importance to self-
identification, behavioral involvement, and self-categorization as a member in a specific 
social group (Dimitrova et al., 2014; Miscenko & Day, 2015). Scholars note that 
collective identity and psychological wellbeing result in greater wellbeing in individuals 
with stronger collective identity consisting of the collection of categorical identities of 
family, religion, and ethnicity (Dimitrova et al., 2014). The collection of identities can 
enhance belongingness and meaningfulness, positively related to wellbeing; positive 





Work can also be considered a source of identity (Kira & Balkin, 2014; Miscenko 
& Day, 2015; Wille & De Fruyt, 2014). Work identity comes from organizational 
membership meanings and is defined as self-meaning for an individual regarding 
characteristics, social roles, or group membership (Kira & Balkin, 2014; Miscenko & 
Day, 2015; Wille & De Fruyt, 2014). When employees define and internalize themselves 
in terms of the organization, they identify with that organization (Kira & Balkin, 2014; 
Miscenko & Day, 2015; Wille & De Fruyt, 2014). Occupational identification is when an 
occupation is internalized within the self, and within occupational socialization, 
personality traits shape individuals over time (Kira & Balkin, 2014; Miscenko & Day, 
2015; Wille & De Fruyt, 2014). With this in mind, Ashcraft (2013) noted, an occupation 
is tied to social identity. Occupations are unique social collective identities, and for some 
individuals, self may be defined by occupational work, which can also affect identity 
outside of the workplace (Ashcraft, 2013; Meister et al., 2014). Even a case of mistaken 
identity at work can negatively affect individuals. Meister et al. (2014) noted how 
important it is to the individual that their true identity, desired, and perceived image was 
recognized, not just their professional identity. Misidentification at work can influence 
relationships wellbeing, wellbeing, and be destructive to the workgroup (Ashcraft, 2013; 
Meister et al., 2014). 
Work Groups 
Most individuals prefer exclusive workgroups in an organization for identity fit, 
meaning, and function (Grant et al., 2014; Millward & Haslam, 2012). In law 
31 
 
enforcement, an exclusive workgroup could be Investigations, Internal Affairs, or SWAT. 
Job titles can also be necessary for an individuals' satisfactory work identity experience 
(Grant et al., 2014; Millward & Haslam, 2012). Self-reflective job titles are symbolic 
social and cultural identity badges, symbols of status, and they construct images that are 
presented to the world (Grant et al., 2014; Millward & Haslam, 2012). Employees who 
are involved in creating job titles are said to lead to a reduction in stress, reduced 
emotional exhaustion, and develop meaningful employee identity within an organization 
(Grant et al., 2014; Millward & Haslam, 2012). Identity is expressed and recognized by 
others, which reduces emotional exhaustion in a stressful work environment and 
increases psychological safety (Grant et al., 2014; Millward & Haslam, 2012). 
Work identity may be associated with relationships, memberships, and roles that 
can reduce the uncertainty of who an individual is (Conroy & O'Leary-Kelly, 2014; Grant 
et al., 2014). Changes in the work environment can trigger disruption, which creates 
uncertainty and modifies the meanings attached to the self (Conroy & O'Leary-Kelly, 
2014; Grant et al., 2014). Misalignment of work and identity can create negative 
emotional consequences (Kira & Balkin, 2014; Miscenko & Day, 2015). Strong 
workgroup identity leads to lower turnover rates, job satisfaction, and positive 
involvement within the organization (Kira & Balkin, 2014; Miscenko & Day, 2015). Job 
satisfaction can occur with a strong professional identity, self-worth, and internalized 




Over-identification can occur when the individual's perception that others believe 
the individual's performance is associated with the organization becomes relevant to the 
individuals' sense of self (Galvin et al., 2015). Although it is extreme, over-identification 
may occur when the self is diminished, organizational goals are internalized, and the 
individuals' wellbeing is sacrificed (Galvin et al., 2015). An individual may identify 
highly with being interchangeable, have a perception of oneness, or is central to an 
organization. The organization then defines the self with power, authority, and interest 
(Galvin et al., 2015). However, loss of this over-identification from an organization due 
to transition may be detrimental to one's psychological wellbeing (Galvin et al., 2015). 
Prescription Opioid Epidemic 
The abuse of prescription and illicit opioids has skyrocketed in recent decades, 
resulting in a crisis affecting virtually all aspects of society. From the 1990s to the 
present, we have seen a notable increase in the prescribing of opioids, the use of opioids, 
and the rate of drug overdoses. In the same period (1997 – 2007), opioid prescriptions in 
the United States skyrocketed an astounding 700% (Boyer, 2012). From 1999 to 2014, 
drug overdose deaths in the United States practically tripled (Rudd et al., 2016; Young, 
2016). In 2010, the annual number of opioid prescriptions reached 210 million, an 
increase of 135 million from 1991 (Guohua et al., 2014). The National Survey on Drug 
Use and Health (NSDUH) anticipated 12.5 million Americans misused a prescription 
medication in 2015 (SAMHSA, 2016). In 2014, 47,055 deaths were found to be a direct 
result of a drug overdose, 28,647 of which were determined to have involved an opioid 
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(Rudd et al., 2016). In 2015, 52,404 deaths were found to be a direct result of a drug 
overdose, 33,091 of which were found to have involved an opioid (Rudd et al., 2016). In 
the one year, between 2014 and 2015, drug overdose deaths increase by 11.4% (Rudd et 
al., 2016). At the same time, opioid death rates increased by 15.6% (Rudd et al., 2016). 
In 2015, the DEA reported overdose deaths, particularly from prescription drugs 
and heroin, have reached epidemic levels (DEA, 2014). It was reported the drug overdose 
death rate substantially rose from 12.3 per 100,000 populations to 16.3 per 100,000 
populations in 2010 and 2015, respectively (Rudd et al., 2016; Young, 2016). The United 
States experienced a significant increase in the number of dispensed opioids as well as 
the number of drug overdoses from the 1990s to the present. Perhaps the most notable is 
the substantial increase in opioid-related overdoses and subsequent fatalities. Before 
2011, the Drug Abuse Warning Network (DAWN) kept track of the number of hospital 
visits that involved pharmaceutical opioids. From 2004 to 2011, DAWN found medical 
emergencies involving pharmaceutical opioids rose 183% (SAMHSA, 2011). This 
number likely would have continued to increase; however, DAWN was discontinued by 
SAMHSA. 
The five-year period between 2010 and 2015 saw a 2.6% increase in the death 
rates for natural, semisynthetic opioids, 20.6% increase in the death rates for heroin, and 
72.2% increase in the death rate for synthetic opioids, excluding methadone (Rudd et al., 
2016). These increases were consistent among all demographics and locations. The years 
between 2010 and 2015 saw a 9.1% decrease in the methadone death rate (Rudd et al., 
2016). Rudd (2016) also attributes the reduction to increased efforts in the early 2000s to 
34 
 
reduce the use of methadone. In late 2016, the DEA classified prescription drugs, heroin, 
and fentanyl as the top drug-related threats to the United States (Rudd et al., 2016; 
Young, 2016). 
Provisional data collected by the CDC indicated in the 12 months between August 
2015 and August 2016, there were 59,417 drug-related overdose deaths (Ahmad et al., 
2018). Compared to the following 12-month period ending August 2017, this number 
increased by 13.3% to 67,344 overdoses (Ahmad et al., 2018). Of the 67,344 drug 
overdoses reported from August 2016 to August 2017, 45,200 were found to be caused 
by opioids (Ahmad et al., 2018). Of the opioid-related overdoses (45,200), synthetic 
opioids, heroin, and natural/semisynthetic opioids attribute to roughly 25,382, 15,358, 
and 14,344, respectively (Ahmad et al., 2018). Notably, the number of synthetic opioid-
related overdoses increased from 15,256 in the period ending in August 2016 to 25,382 in 
August 2017 (Ahmad et al., 2018). NSDUH projected "30.5 million Americans aged 12 
or older were current illicit drug users" (SAMHSA, 2018). NSDUH defined a current 
drug user as an individual who used an illicit drug last month (SAMHSA, 2018). When 
categorized by the drug of choice, marijuana was found to be the most commonly used 
(26.0 million), followed by prescription pain relievers (3.2 million). In 2017, NSDUH 
estimated that 2.1 million people were suffering from opioid addiction (SAMHSA, 2018). 
The overwhelming majority (1.7 million) were said to have a prescription pain reliever 




When discussing drug overdose statistics, it is important to note the difficulty in 
ensuring the accuracy of the data. Drug overdoses often occur when an individual ingests 
more than one type of drug. However, depending on the timeliness of the autopsy, it may 
be difficult, if not impossible, for the medical examiner to determine which drug caused 
the overdose. Hedegaard et al. (2017) noted that in roughly 1 in 5 drug overdoses, the 
type of drug is not listed on the medical certificate. With that said, it is possible that the 
number of opioids involved overdoses is underreported. 
As news stations continue to inundate viewers with heart-wrenching statistics, 
politicians aim to present their angle on the daily circuit. The White House works to 
develop a plan to tackle the ever-growing epidemic, and we still appear no closer to a 
drug-free society. Each state has taken it upon themselves to develop legislation designed 
to combat the opioid epidemic in their respective territories better. However, addicts 
continue to outsmart the system and exploit areas with weaker legislative policies. This 
literature review aims to deeply explore the opioid epidemic, more specifically, the series 
of events that cultivated an environment conducive to growing the epidemic, the growth 
and danger of synthetic opioids, and the importance of naloxone in working to prevent 
opioid-related overdoses from turning fatal. 
Defining Pain 
In 1998, "pain" was officially classified as the fifth vital sign (Quinones, 2015). 
Pain is primarily viewed in the same category as pulse, blood pressure, respiration, and 
body temperature (Quinones, 2015). This classification represents a seismic shift in how 
the medical community responds to and treats a patient's pain level. Before the second 
36 
 
half of the 1900s, many doctors publicly expressed their distaste for pain management 
treatment. These medical professionals argued that pain was beneficial to the patient and 
beneficial and necessary for the healing process (Lembke, 2012). However, as medicines 
began to evolve, the views on pain and pain management followed suit. 
In the late 1980s, medical professionals were encouraged to view pain as a 
subjective experience for the patient (Lembke, 2012). This notion was reinforced through 
the use of patient satisfaction surveys. A typical patient satisfaction survey includes a 
component of the doctor's ability to address the patient's pain (Lembke, 2012). The 
results of these surveys may be used to determine a physician's bonus, job security, etc. 
Doctors who refused to prescribe pain killers to patients who described their pain level 
using terms such as "unbearable," "intolerable," "debilitating," etc., may be viewed as 
withholding necessary treatment measures. One patient summed up the conundrum 
doctor's face; she stated: I am addicted to (opioids), and it's the doctors' fault because they 
prescribe them. But I'll sue them if they leave me in pain" (Lembke, 2012). 
A typical medical professional does not undergo extensive training in pain 
management (Lembke 2012; Quinones 2015).  However, on the job training indicates that 
a quick visit with a patient resulting in a pain prescription is more cost-effective than the 
alternative (Lembke 2012; Quinones 2015).  Doctors who choose to take the time to 
educate their patients on addiction or utilize counseling techniques may be criticized for 
their inability to "turn patients over" quickly and efficiently (Lembke 2012; Quinones 
2015).  These shifting views, coupled with the popular notion that pain counteracts the 
euphoric effects of opioids, has led to disaster (Lembke 2012; Quinones 2015).  As 
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physicians began to open their minds to the use of prescription opioids, pharmaceutical 
companies such as Purdue Pharma, seized the opportunity to fill a growing need (Lembke 
2012; Quinones 2015).   
Big Pharma. Purdue Pharma first introduced OxyContin in 1996 (Zee, 2009). 
Purdue Pharma revolutionized the advertising tactics for pain medicine. They utilized 
aggressive techniques and substantial monetary tactics to capture the market. In 2000, 
OxyContin sales reached over $1 billion, a substantial increase from the $48 million 
posted in 1996 (Zee, 2009). These financial strides were the result of aggressive 
advertising, coupled with a very liberal approach to pain management (Zee, 2009).  
In the five years between 1996 and 2001, Perdue Pharma held over 40 national 
conferences, in which more than 5,000 medical professionals accepted invitations to 
attend, free of charge (Zee, 2009). While in attendance, medical professionals were 
recruited and subsequently trained to speak on behalf of Purdue Pharma (Zee, 2009). 
Specifically, Purdue Pharma targeted doctors who demonstrated a high tendency to 
prescribe medications (Zee, 2009).  Additionally, Purdue Pharma developed a lucrative 
incentive system designed to motivate sales representatives to utilize any marketing 
tactics to increase sales in their respective territories (Zee, 2009). In 1996, the Purdue 
Pharma sales force consisted of 318 employees, and this number increased to 671 by 
2000 (Zee, 2009). Sales representatives inundated doctors with OxyContin merchandise 
such as hats, pens, t-shirts, etc.  
Perhaps most notably, a chart that indicated a patient's prescription for another 
pain medication was crossed out and replaced with OxyContin (Quinones, 2015). 
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Additionally, Purdue Pharma distributed a coupon that allowed new patients to receive a 
free supply of OxyContin (Zee, 2009). Regarding the OxyContin marketing campaign, 
the DEA stated no company had ever utilized such tactics in the advertising of a schedule 
II drug in history (Quinones, 2015). 
Purdue Pharma utilized numerous different avenues such as videos, conferences, 
spokespeople, etc. to inform consumers that the chance of patients becoming addicted to 
OxyContin was extremely rare. Purdue Pharma cited the timed-release formulation of 
OxyContin to present the idea that it was less addictive. The company relied upon that the 
slow release of the opioid, prevented patients from experiencing extreme highs and lows, 
which are prevalent in addiction (Zee, 2009). Sales representatives were trained and 
encouraged to communicate that the chance of addiction was "less than one percent" 
(Zee, 2009). Purdue Pharma exploited the limited staff of the Food and Drug 
Administration (FDA) and released OxyContin promotional videos to medical 
professionals before receiving the FDA stamp of approval. This video was later deemed 
inappropriate due to the minimization of the risk and promotion of the unsupported 
benefits. However, in 2007, a partner company of Purdue Pharma, Purdue Frederick 
Company Inc., along with three high ranking employees pled guilty to the 
misrepresentation of OxyContin (Zee, 2009). They were subsequently ordered to pay 
$634 million in damages. 
In August 2010, Purdue Pharma released a new version of OxyContin. This new 
version was designed to help prevent users from crushing and subsequently snorting of 
injecting the pills. Data collected from the Rocky Mountain Poison Control Center Drug 
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Diversion Monitoring Program demonstrated a subsequent decrease in the demand for 
OxyContin following the release of the new formula (Iwanicki et al., 2016). The same 
data set showed that the illicit market price for OxyContin dropped 50 percent, following 
the release of the pills' reformulated version (Iwanicki et al., 2016). Cicero et al. (2012) 
conducted a study to gauge the effectiveness of the reformulation. Before the release, 
35.6% of surveyed respondents designated OxyContin as their preferred drug of choice 
(Cicero et al., 2012). This percentage dropped to 12.8%, 21 months following the release 
of the reformulated pills. All participants who admitted to abusing both versions of 
OxyContin preferred the original formula (Cicero et al., 2012). 66% of the participants, 
who previously indicated OxyContin as their drug of choice, switched to a different 
opioid (typically heroin) following the release of the reformulation (Cicero et al., 2012). 
One participant stated, "most people that I know don't use OxyContin to get high 
anymore. They have moved on to heroin [because] it is easier to use and much cheaper 
and available" (Cicero et al., 2012). Although not necessarily corroborated by statistical 
data, it is essential to note the previous statement, maybe a reliable indicator for the 
gateway between prescription opioids, specifically OxyContin and heroin use. 
Prescription Drug Monitoring Program. The National Alliance for Model State 
Drug Laws defines a prescription drug monitoring program (PDMP) as a centralized, 
comprehensive database that houses statewide data regarding prescribed substances 
(DEA, 2016). Currently, most states require practitioners to diligently update the PDMP 
with patient information, specific dosage details, current medications, etc. (Astho, n.d.). 
Depending on the state, this information may be provided to various agencies or parties 
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such as public health agencies, physicians, public safety agencies, pharmacies, etc. 
(Astho, n.d.). 
The first PDMP was established in California in 1939 (Wixson et al., 2015). By 
the early 1990s, 10 states had active PDMPs (Wixsonet al., 2015). At this time, there was 
no established blueprint to follow when establishing a PDMP. As a result, each PDMP 
differed in the design of the program. The overall goal of the early PDMPs was unified 
among the states (Wixsonet al., 2015).  Unfortunately, the lack of standardization among 
the different programs made it increasingly difficult to open communication lines and 
share information among neighboring states (Wixsonet al., 2015). 
In the early 2000s, the abuse and diversion of controlled substances continued to 
increase. With the financial support of Congress, the Bureau of Justice Assistance (BJA), 
Office of Justice Programs in the U.S. Department of Justice, established the Harold 
Rogers Prescription Drug Monitoring Program (Wixsonet al., 2015). These grants were 
designated to assist states in the planning, implementation, or enhancement of a PDMP. 
The U.S. Department of Health and Human Services followed in kind and created the 
National All Schedules Prescription Electronic Reporting Act (NASPER) as another 
support element (Wixsonet al., 2015). For the Harold Rogers Grant and NASPER Act, 
President Obama proposed allocating $7 million and $2 million, respectively, in the 
budget for the fiscal year 2010 (Wixsonet al., 2015). 
Each state has the autonomy to develop and utilize the PDMP to serve the state's 
needs best. The majority of the established PDMPs are housed in the state public health 
agency; however, a handful of states house the PDMPs with a law enforcement agency 
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(Astho, n.d.). The administrative details and the housing agency differ among states; 
however, the underlying concept of the PDMP is typically similar (Wixsonet al., 2015). 
Generally, PDMPs are established in an attempt to combat the diversion of controlled 
substances. However, many states cite the importance of improving the pharmaceutical 
treatment of patients (Astho, n.d.). Critics of PDMPs cite the danger of refusing to 
prescribe patients who are in legitimate pain. 
The lack of uniformity among state PDMPs has made it increasingly difficult for 
states to share PDMP data. As a result, doctor shoppers may travel across state lines to 
receive prescriptions from doctors, unaware of their medical history in other states. Other 
differences in PDMPs among states may include the number of scheduled drugs 
(Gugelmann et al., 2012). For example, the PDMP in Pennsylvania only requires medical 
professionals to track the dispensing of Schedule II drugs (oxycodone and 
hydromorphone). More commonly, PDMPs require the tracking of Schedule II-IV drugs 
(Gugelmann et al., 2012). Additionally, states may differ in the time allowed before 
updating the system (Gugelmann et al., 2012). For example, Alabama allows medical 
professionals and pharmacies a two-week window to update the system with newly 
acquired data (Alabama Department of Public Health, 2019). 
Another difference among states is the accessibility of the PDMP. Typically, 
states allow a combination of pharmacists, prescribers, medical professionals, and law 
enforcement agencies, limited or full access to the database. Various law enforcement 
agents have expressed frustration with their lack of access to the information housed in 
the PDMP. Gugelmann et al. (2012) stated that a handful of states prevent prescribers 
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from accessing the data available on the PDMP before prescribing a controlled substance. 
This legislation is designed to prevent the subscriber from facing civil liability. One could 
argue that this policy may negate the purpose of the PDMP. The inability of out of state 
data sharing among states limits the effectiveness of PDMPs. The differences among 
states allow addicts to exploit the weaknesses of various states and reap the potential 
benefits of less stringent legislation. 
The Climate in Alabama 
Many Alabamians are prescribed opioids for various ailments; however, many of 
these individuals become long-term users. A report by the CDC, Alabama leads the 
nation in opioid prescriptions, with an average of 1.2 prescriptions per person compared 
to the national average of 0.71 (CDC Wonder, 2018). As a result of the ever-growing rate 
of addiction, there is an associated increase in illicit opioid use, which directly impacts 
the state's economy (Gau and Brooke, 2017).  On the law enforcement front, economic 
impacts include an increase in the costs for law enforcement officers and their associated 
equipment, prosecution, and incarceration of offenders, as well as an emergency room 
and hospitalization of drug users (Gau and Brooke, 2017). 
In the early 2000s, Alabama took a wait and see attitude towards prescription drug 
diversion. Locals and addicts from neighboring states traveled highway 65, seeking to fill 
prescriptions. As more states began implementing PDMP legislation, Alabama was still 
relatively open and became a destination for those addicted to opioids. The lax regulatory 
oversite of physicians and pharmacies, coupled with the lack of prescription drug 
monitoring programs, cultivated an environment conducive to prescription drug diversion 
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(Alabama Board of Medicine, 2018). Between 2005 and 2010, the prevalence of 
oxycodone related deaths in Alabama continued to climb (Department of Justice, AG 
Remarks, 2018). 
Johnson et al. (2014) states in 2010, 98 of the top 100 oxycodone dispensing 
prescribers were located in Florida. During this time, four of the five Alabama counties 
that border Florida were top opioid prescribers in the nation (CDC, 2019). Of the 67 
counties in Alabama, 40 of those counties were prime subscribers (CDC, 2019). In 2010, 
the DEA reported that Alabama had two unregulated pain management clinics (Alabama 
Board of Medicine, 2017). As the opioid epidemic continues to plague the nation, we 
have seen a steady increase in opioid-related deaths in the United States. 
A qualitative analysis conducted on law enforcement perceptions of prescription 
pill abuse indicated that many law enforcement officers are quick to disregard the 
severity of prescription pill addiction (Gau & Brooke, 2017). With hard drugs such as 
heroin, cocaine, meth, etc. on the streets, there was little time to focus on a doctor 
prescribed medication. One law enforcement officer stated, "Five or six years ago it was 
like the wild, wild west. There was no regulation. They [pill-mill physicians and owners] 
weren't afraid. They in no way had any fear of arrest or of being incarcerated of anything 
like that" (Gau & Brooke, 2017). Notably, a portion of the individuals interviewed argued 
that the pill-mill clinics might have outsmarted the system and simply relocated (Gau & 
Brooke, 2017). 
In recent years, there has been an increase in the successful prosecution of doctors 
involved in pain management clinics. However, in order to charge a physician under 
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Alabama statues regarding the lawful prescription of controlled substances, the 
prosecutor must prove the physician "knowingly" prescribed opioids to patients who 
were abusing the medication of distributing for financial gain (Gau & Brooke, 2017). 
Essentially, the prosecutor must prove that the doctor incorrectly gauged the level of pain 
experienced by the patient (Gau & Brooke, 2017). Pain management clinics are mostly 
legal, as is the distribution of prescription opioids (Gau & Brooke, 2017).  Therefore, law 
enforcement and prosecution must identify and prove the criminal intent of the general 
legitimate operation (Gau & Brooke, 2017). Law enforcement officers cited numerous 
difficulties in building air-tight cases against physicians. For one, doctor-patient 
confidentiality makes it difficult for law enforcement officers to access a patient's 
medical records (Gau & Brooke, 2017). Additionally, and perhaps most notable is the 
knowledge possessed by physicians (Gau & Brooke, 2017). One law enforcement officer 
mentioned he was ill-equipped to determine how many pills a patient should receive, 
making it challenging to prove ill intent (Gau & Brooke, 2017). 
Diversion of Prescription Pills 
The overwhelming presence of pain clinics or pill-mills coupled with the ease of 
obtaining prescriptions for opioids and onsite pharmacies created the perfect combination 
for diversion. In this case, diversion is the act of transferring legally obtained prescription 
opioids out of the individual's control for whom it was prescribed and distributing for 
illicit use (Surratt et al., 2014). The lack of pill-mill legislation in Alabama, throughout 
the first decade of the 2000s, made it extremely difficult to identify and subsequently 
combat instances of diversion. Many patients utilized the concept of "doctor shopping" to 
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acquire additional prescriptions. A "doctor shopper" is a patient who actively seeks 
medical prescriptions from multiple doctors without informing the other doctors of their 
obtained medicines (Melville, 2013).  In a study conducted in the United States, 
researchers concluded that the average doctor shopper received 32 prescriptions for 
opioids from ten different medical professionals (Melville, 2013). Other methods that 
often lead to diversion include forging prescriptions, stealing from patients and 
pharmacies, and under the counter sales by physicians. Between 2008 and 2010, pill-
mills were found to be the primary source of prescription opioids sold on the illicit 
market (Surratt et al., 2014). 
In 2014, the NSDUH, reported the majority (63.6%) of illicit prescription pill 
users, received the drugs from friends or relatives (Substance Abuse and Mental Health 
Service Administration, 2014). The remaining individuals received drugs from physicians 
(21%), drug dealers (4.3%), and online avenues (0.1%) in that order (Substance Abuse 
and Mental Health Service Administration, 2018).  
Using law enforcement data in Alabama, researchers found the diversion rate for 
oxycodone and several other opioids, decreased following the PDMP implementation and 
various legislative efforts (Surratt et al., 2014). Surratt (2014) found that the diversion of 
fentanyl, hydromorphone, buprenorphine, and tramadol neither increased nor decreased 
during the analysis period. 
Heroin was first created in 1874 by a Bayer Pharmaceutical chemist, Heinrich 
Dresser (Quinones, 2015). Initially, heroin was marketed as a non-addictive pain remedy. 
The claim of the non-addictive nature of the drug, coupled with the lack of available 
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medicine, resulted in widespread use and subsequent high rates of addiction (Quinones, 
2015). Around this same period, numerous government campaigns sought to frame 
addicts as criminals (Quinones, 2015). Although the medical benefits of heroin were de-
debunked, heroin soon became a staple on the illicit market. Heroin was a dealer's dream, 
cheap to make, easy to produce, and simple to traffic. Over time competition among 
dealers led to diluted products and discounted rates. 
Similar Effect, Different Chemical Makeup 
In the 1970s, US Congressman Robert Steele, analyzed the drug use report of US 
service members during the Vietnam War (Frontline, 2014). Steele's analyzed reports 
concluded an addiction rate of 10 – 15% (Frontline, 2014). This finding, together with the 
overwhelming amount of Vietnam service members who returned from the war addicted 
to heroin, fast-tracked the issue to then-President Nixon's drug agenda. In 1971, President 
Richard Nixon declared drugs, particularly heroin, to be the biggest enemy the country 
faced (Gerstein & Green, 1993). 
Currently, you cannot listen to a news broadcast without hearing a discussion 
centering on the drug epidemic plaguing our nation. However, although heroin is a vital 
aspect of the current epidemic, the user population is starkly different from that of the 
1970s (Cicero et al., 2014). Historically, heroin users were viewed as minorities living in 
low-income, primarily urban areas. Currently, the stereotyped heroin user is an affluent 
White  living in a suburban or rural area of the country (Cicero et al., 2014). The shift in 
the average heroin consumer may be attributed in part to the increase in prescription 
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opioids' use and the subsequent transition from prescription opioids to heroin (Cicero et 
al., 2014). 
Cicero et al. (2014) conducted a study in which they examined the transition from 
opioid use to heroin and vice versa. Of the participants who reported they began using 
opioids in the 1960s, at least 80% indicated their experimentation with opioid drugs, 
began with heroin (Cicero et al., 2014). When examining the participants who started 
using opioids in the 2000s, 75% reported their experimentation began with a prescription 
drug (Cicero et al., 2014). Cicero et al. (2014) found that the current wave of heroin users 
exhibited similar patterns of abuse as those individuals abusing prescription opioids. In 
that sense, the results indicated that prescription opioid users might shift to heroin at 
some point in their addiction timeline. Numerous studies have determined that heroin is 
easily accessible and subsequently more affordable than prescription opioids. This quote 
exemplifies the potential conundrum many prescription opioid users may face: 
All of my friends use heroin, and I know multiple people who will sell it to me or 
help me find some who has it. Also, if I have money, I wanna spend it on 
something I know will get me high. If I buy pills, I might not have enough money 
to make sure I get high. (Cicero et al., 2014, p. 825) 
In a study of 103 patients, derived from individuals entering drug treatment 
programs in the United States between 2009 and 2012, 47.4% reported using OxyContin, 
30 days before the reformulation of OxyContin. Following the reformulation of 
OxyContin, this number dropped to 30% (Moyer, 2013). In the same time frame, using 
the same study population, reports of heroin use practically doubled (Moyer, 2013). 
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Although there is not a clear line connecting the increase in heroin use to the crackdown 
on prescription pill mills and diversion, many argue this relationship is casual at the very 
least. 
Prescription Opioids to Heroin  
In 2014 the deputy attorney general, James M. Cole, spoke at the "Pills to 
Needles: The Pathway to Rising Heroin Deaths" Event. Deputy Attorney General Cole 
stated the following in regards to the current opioid epidemic: 
Abuse of prescription drugs leads to dependency, and that dependency leads to 
demand for more prescription drugs. That demand, users find, ultimately cannot 
be satisfied by the harder-to-obtain and more expensive prescription pills. That is 
where heroin problems sneak in. The readily available and lower cost of heroin 
makes it a smooth and cheap alternative with tragic consequences. (Department of 
Justice, 2014, p. 2) 
Deputy Attorney General James M. Cole stated the DEA revamped and increased 
efforts along the border to address heroin trafficking better. The amount of heroin seized 
along the southwest border, skyrocketed 320% from 2008 to 2013. This statistic is 
reflective of both an increase in the attempt to traffic heroin across the border, as well as 
the exhaustive efforts of the DEA to address the issue (Department of Justice, 2014). 
In 2013, it was estimated that 681,000 individuals engaged in heroin use in the 
past year. This number represented an 82.6% increase from the data collected in 2007 
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2014; 
Votawet al., 2016). Notably, the 2017 NSDUH estimated 886,000 people had used heroin 
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in 2017. This number represents a rise of over 200,000 people from the data collected in 
2013. 
Pain and addiction specialists warn that by shutting down pill mills and 
eliminating the prescription opioid users' ability to access their prescriptions, we may see 
these users turn to the illicit drug market to obtain opioids (Moyer, 2013). Heroin, being a 
cheaper and more available product on the illicit market, may serve as a substitute for 
prescription opioid users, in the event the user can no longer obtain or afford prescription 
opioids (Moyer, 2013). Nicholas Kardaras, Ph.D., stated prescription opioids and heroin 
cause the same neurochemical effect, which may entice prescription opioid users, who 
are strapped for cash, to seek heroin, a cheaper alternative (Moyer, 2013). Pain 
management specialist, Lynn Webster MD, revealed she had seen an increasingly high 
number of patients switch from prescription opioids such as OxyContin to heroin after 
OxyContin was reformulated to prevent users from crushing and injecting (Moyer, 2013). 
From 2009 to 2012, many states enacted various legislative efforts to combat the 
diversion of prescription opioids. Although these efforts are often viewed as successful, 
in terms of reducing the amount of pain management clinics and the illicit diversion of 
prescription opioids, many researchers argue these changes may have led to an increase 
in heroin and other easily accessible street drugs (Compton et al., 2016). The National 
Survey on Drug Use and Health (NSDUH) reported that 79.5% of new heroin users 
indicated they had used a prescription opioid before heroin use (Dart et al., 2015). The 
CDC reported a slight decrease in opioid-related deaths in 2012 and 2013; however, in 
2014, the number of opioid-related deaths increased from 16,235 to 18,893 (Compton et 
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al., 2016). In 2014, the NSDUH projected that 917,000 people had engaged in heroin use 
during their lifetime; this represents a 145% increase since 2007 (Compton et al., 2016). 
Additionally, there were 10,574 heroin-related deaths in 2014, up from 1,842 in 2000 
(Compton, 2016). Muhuri et al. (2013) conducted a study utilizing data collected from the 
2002 – 2011 NSDUH study. The results indicated a notable association between using 
pain relievers with no medical purpose (NMPR) and heroin in the year following NMPR 
use (Muhuri et al., 2013). Muhuri et al. (2013) reported that the initiation of heroin use 
was 19 times higher in individuals who reported using NMPR. 
Dart et al. (2015) conducted a study to examine diversion and abuse trends 
between 2002 and 2013, using five programs from the Research, Abuse, Diversion, and 
Addiction-Related Surveillance System (RADARS). Data from the National Poison Data 
System indicated that heroin-related deaths are inversely correlated with prescription 
opioid-related deaths (Dart et al., 2015). Dart et al. (2015) reported that heroin-related 
deaths remained constant between 2002 and 2010; however, heroin-related deaths 
increased yearly from 2010 to 2013 (Dart et al., 2015). In contrast, prescription opioid-
related deaths spiked between 2002 and 2006, remained constant from 2006 to 2008, and 
steadily decreased from 2010 to 2013 (Dart et al., 2015). The availability of prescription 
opioids began to increase in the 1900s and continued upward until a plateau in 2011. Dart 
et al. (2015) reported findings consistent with numerous other studies, which indicated an 
increase in abuse of prescription opioids before 2011. 
According to the Drug Abuse Warning Network (DAWN), hospital medical 
emergencies associated with prescription opioids increased 183% from 2004 to 2011 
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(Dart et al., 2015; Drug Abuse Warning Network, 2013). However, recent trends indicate 
a decrease in the availability and subsequent diversion of prescription opioids. Dart et al. 
(2015) attributes this reduction to various legislative measures and an associated decrease 
in prescription pill mills, etc. Notably, although the direct cause may be unknown, this 
study demonstrates the fluctuation of the rate of opioid and opioid analgesics abuse is 
correlated with the rise in heroin-related deaths (Dart et al., 2015). 
Peavy et al. (2012) conducted a study in which they interviewed 553 syringe-
exchange clients, 443 admitted to heroin in the four months before the interview. Of these 
participants, 39% reported using some sort of prescription opioid before experimenting 
with heroin (Peavy et al., 2012). These participants were typically younger, White , and 
appeared to have a more stable living situation. These results can have implications for 
the trajectory of drug use in the United States in the past decade. For one, the indication 
that those individuals who reported using prescription opioids before heroin were 
generally younger than the alternative may be the result of the availability of prescription 
opioids through both licit and illicit channels. This notion would be in line with the 
argument that prescription opioid non-medical use may be a gateway to heroin use. 
Synthetic Opioids 
Synthetic opioids and natural opioids are similar in that they target the same 
receptors. However, natural opioids are naturally occurring substances, whereas synthetic 
opioids are synthesized in a laboratory (DEA, 2017). Synthetic opioids are cheaper to 
produce and more accessible to acquire than natural and semisynthetic opioids, such as 
heroin.  As a result, many street dealers mix synthetic opioids with heroin, in order to 
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increase profits. Often, synthetic opioids are clandestinely produced as counterfeit 
prescription opioids, such as OxyContin (DEA, 2017). The abuse pattern of synthetic 
opioids is very similar to heroin and prescription opioids (DEA, 2017). However, 
synthetic opioids are extremely and often fatally potent. Consumers cannot determine the 
potency of a clandestinely produced synthetic opioid, which heightens the risk of 
overdose (DEA, 2017). Prekupec et al. (2017) stated there were 9,580 deaths attributed to 
synthetic opioids, excluding methadone, in 2015. Recently collected law enforcement 
data demonstrated a surge in the street presence of novel synthetic opioids (NSOs), 
including but not limited to acetyl, fentanyl, butyrylfentanyl, furanylfentanyl, and U-
47700 (Prekupec et al., 2017). 
Organized crime groups identified the potential profit in the drug trade and have 
spent recent decades infiltrating the marketplace. In order to stay one step ahead of law 
enforcement, organized crime groups have partnered with drug manufacturers located 
primarily in China to benefit from the manufacturing capability in Asian countries 
(Prekupec et al., 2017). As the United States government works to designate new illicit 
substances as illegal, manufacturers are developing analogs of these substances, to serve 
as a replacement (Prekupec et al., 2017). Recent estimations indicate hundreds of 
thousands of counterfeit prescription pills can be manufactured from just one kilogram of 
new psychoactive substances (NPS), such as fentanyl analogs (Prekupec et al., 2017). 
These tablets can be purchased online and imported through international delivery 
services and US mail. The small quantities of each shipment make it extremely difficult 
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for mail inspectors and law enforcement officers to identify and seize the packages 
(Prekupec et al., 2017). 
As China continues to create fentanyl analogs, US law enforcement agencies and 
subject matter experts struggle to stay up to date with the latest trends and substances. In 
order for scientists and toxicologists to determine the chemical composition of each new 
analog, the substance must be identified and confiscated by law enforcement and 
quantified in the seized drug (Prekupec et al., 2017). Biological samples from those 
individuals who ingested the substance can be used for testing. Notably, a standard urine 
toxicology screen can detect heroin and morphine but cannot identify opioids with unique 
structures, such as fentanyl and fentanyl analogs (Prekupec et al., 2017). Prekupec et al. 
(2017) explained that fentanyl could be identified using an enzyme-linked 
immunosorbent assay (ELISA). However, more sophisticated methods are needed to 
differentiate between fentanyl and fentanyl analogs (Prekupec et al., 2017). Prekupec et 
al. (2017) stated: "to date, no antibody-based methods are commercially available to 
detect non-fentanyl analogs such as AH-7921, U-47700, or MT-45." It has become 
challenging to develop immunoassays for all NSOs, at the rate of which they are created. 
With that said, it is suggested that the frequency of NSO use is likely underreported. 
U-47700 "Pink." U-47700, commonly referred to as "pink," is a synthetic opioid. 
In November 2016, the DEA officially classified U-47700 as a Schedule I drug, which 
means it offers no medical benefit but yields strong potential for addiction. The National 
Forensic Laboratory Information System (NFLIS) indicated the first report of U-47700 
occurred in October 2015 (DEA 440, 2016). The DEA reported based on the collected 
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evidence, the consumption pattern of U-47700 mirrors heroin and prescription opioids 
(DEA 440, 2016). Recent seizures identified U-47700 in tablet form, designed to appear 
as a pharmaceutical opioid or stamped with logos to mimic heroin (DEA 440, 2016). 
Reports indicate that U-47700 has been identified as a solitary and mixed substance with 
various substances such as heroin, fentanyl, and fentanyl analogs (DEA 440, 2016). The 
majority of U-47700 is distributed through online channels or street dealers. Since this 
substance is distributed through non-regulated sources, the user is in grave danger of 
overdosing. Currently, U-47700 is advertised through various online channels as a 
"research chemical" (DEA 440, 2016). The DEA identified at least 46, U-47700 related 
fatalities from late 2015 to mid-2016 (DEA 440, 2016). 
In 2017, Alabama officials began seeing a different version of U-47700 in 
overdose cases. On the street, it is called "gray death" because of the similar appearance 
to concreate. Several reports note the need for two doses of naloxone to revive overdose 
victims (Alabama Department of Public Health (ADPH), 2019). It is important to note; 
the Medical Examiners Commission did not explicitly request reporting of occurrences of 
U-47700. Due to the rapid rise of deaths associated with U-47700, many Medical 
Examiner Districts voluntarily reported data; however, the data is not complete. 
Fentanyl 
In the 1960s, Janssen Pharmaceuticals manufactured a synthetic opioid, referred 
to as Fentanyl (Lozier et al., 2015). The CDC (2017) defines fentanyl as a "synthetic and 
short-acting opioid analgesic," typically prescribed for patients diagnosed with advanced 
forms of cancer. The potency of fentanyl makes it incredibly dangerous. In some cases, 
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ingestion of only .25 mg can be fatal. Notably, a dose of fentanyl can be up to 100 times 
more potent than morphine and 30-50 times stronger than heroin (CDC, 2017; DEA, 
2015). Dealers have been using illicitly manufactured Fentanyl (IMF) or a fentanyl 
analog to mix with heroin, to meet the ever-rising heroin demand and match the demand, 
without diminishing the potency (Bode et al., 2017). 
In the 1970s, clandestine laboratories began to synthesize fentanyl derivatives; 
these analogs were comparable in pharmacokinetics but differed in potency (Lozier et al., 
2015). Lozier et al. (2015) stated in the early 1980s, IMF and fentanyl analogs were 
flooding the illicit channels. Misaildi et al. (2017) reported over 1400 fentanyl analogs 
had been manufactured in the recent decades, of which pharmacologists have studied 
200, and 12 have been identified in the illicit drug market in the last five years. In past 
decades, we have seen several waves of fentanyl-related overdoses throughout the 
Country (Lozier et al. (2015) . In 2013, as a result of fentanyl seizures, the number 
increased to 3,344 (DEA, 2015). Traces of Fentanyl were identified in 90% of the 281 
accidental overdoses, which occurred in Ohio for two months in early 2017 (Morgan & 
Jones, 2018). 
The DEA stresses the importance of differentiating between pharmaceutical 
fentanyl and illicitly manufactured Fentanyl (IMF). Although the diversion of 
prescription fentanyl is undoubtedly a factor, the drastic increase in fentanyl-related 
overdose deaths can primarily be attributed to the IMF (DEA, 2016a). Prekupec et al. 
(2017) stated that the number of overdose deaths involving synthetic opioids might be 
grossly underreported. Typically, medical examiners and crime laboratories do not 
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conduct testing to determine the presence of Fentanyl of NSOs, unless instructed to do so. 
As a result, overdose, which may be solely attributed to heroin, maybe mischaracterized. 
Not only is fentanyl extremely potent, but it is also easy to acquire through the 
dark web or a tor browser (software that allows access to the dark web) and significantly 
more profitable than heroin (Kulbarsh, 2016). In the period between 2010 and 2014, 
heroin-involved deaths skyrocketed, increasing more than three-fold (Macmadu et al., 
2017; Compton, Jones & Baldwin, 2016). Additionally, from 2013 to 2014, synthetic 
opioid-related overdoses increased by 80% (Macmadu et al., 2017; Rudd et al., 2016). 
Gladden et al. (2016) found that when purchasing drugs through illicit channels, 
and the user is typically unaware of the chemical makeup of the substance. Therefore, it 
is difficult for a user to argue how much he/she must inject to achieve the high but avoid 
the overdoses. Drug purchasers who unknowingly purchase products, laced, or cut with 
fentanyl, are at a heightened risk of overdosing due to the intense potency of fentanyl. 
Macmadu et al. (2017) conducted a study to examine the use of fentanyl among young 
adults who reported non-medical prescription opioid use in the United States. Of the 
participants who reported using fentanyl in the six-month study period, 59% admitted 
being unaware that they were using fentanyl until after consumption. Unanimously, the 
participants recognized the potential overdose danger of using fentanyl (Macmadu et al., 
2017). 
A DEA report noted that 251 deceased individuals were found to have fentanyl in 
their system in 2012 (DEA Fentanyl, 2016). This number increased by 263% to 911 in 
2015 (DEA Fentanyl, 2016). In 77.4% of the noted cases in 2015, fentanyl was 
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determined to be the cause of death. These number represents a 418% increase from the 
data collected in 2012 (DEA Fentanyl, 2016). From 2013 to 2014, fentanyl submissions 
in Alabama jumped 493% from 33 to 196 (CDC, 2016). At the same time, Alabama 
experienced a 115% increase in fentanyl-related deaths, which totaled 397 fentanyl-
related deaths (Gladden, Martinez & Seth., 2016). In the period between January and 
June 2015, fentanyl analogs (acetyl fentanyl, butyryl fentanyl, and beta-
hydroxthiofentanyl) were identified in 49 lethal drugs, overdoses (Gladden, Martinez & 
Seth., 2016). Gladden et al. (2016) identified additional substances present in the wake of 
a deadly fentanyl overdose. From 2013 to 2014, 33% of fentanyl deaths were positive for 
cocaine, 19% tested positive from heroin, and 28% tested positive for morphine 
(Gladden, Martinez & Seth, 2016). 
It is important to note, heroin quickly metabolizes to morphine, and therefore it is 
possible the morphine positive fentanyl deaths could be attributed to the metabolism of 
heroin (Harruff eta l., 2015). The detection of other illicit substances present in the case 
of a fentanyl overdose provides support for the notion that illicitly manufactured fentanyl 
is likely to blame. The dramatic increase in fentanyl-related deaths demonstrates the high 
potency of fentanyl and the danger of engaging in IMP use. Notably, most recreational 
and habitual drug users are often unaware of the heroin or other illicit substances they are 
ingesting may be mixed with fentanyl or a fentanyl analog. 
Acetyl Fentanyl 
Acetyl Fentanyl is a synthetic opioid derived from Fentanyl. The chemical 
composition of acetyl fentanyl may be similar to Fentanyl; however, the DEA classifies 
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acetyl fentanyl as a Schedule I substance without medical use (Stogner, 2014). Although 
acetyl fentanyl has been linked to a slew of overdoses in recent years, many deaths and 
overdoses associated with acetyl fentanyl may be deemed heroin-related, due to the 
absence of testing identify the chemical makeup further (Stogner, 2014). Stogner (2014) 
stated in the case of an overdose, patients would likely respond similarly to naloxone, as 
in heroin overdose; however, a more potent dosage would probably be needed. 
In 2014, drug traffickers were exploiting a grave weakness in the war against 
drugs. At this time, acetyl fentanyl was not scheduled under the Controlled Substance 
Act. The fact that it was a fentanyl analog made it illicit for human consumption. 
Nevertheless, if the packaging indicated the contents were not for human use, it would be 
difficult to seize and subsequently prosecute (Stogner, 2014). Stogner (2014) referred to 
this conundrum as the "analog loophole." It was important to note in July 2015, acetyl 
fentanyl officially became classified as a Schedule I substance. However, the "analog 
loophole" is still very problematic due to the immense efforts of clandestine drug 
manufacturers to create new analogs, and inundate the marketplace, before law 
enforcement can identify the new products. 
Dealers may mix a small amount of heroin with a dose of acetyl fentanyl and 
market the product as pure heroin to keep buyers content and increase profits. This 
mixing allows the dealer to use less heroin, which is more expensive and harder to traffic 
products. Stogner (2014) mentioned that acetyl fentanyl might be manufactured and 
packaged to imitate prescription pills, typically oxycodone. Stogner (2014) stated that 
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analogs of schedule I substances have been marketed as cleaners and plant food and sold 
in various drug paraphernalia stores. 
Butyrylfentanyl 
Butyrylfentanyl, a fentanyl analog, was first discussed in scientific journalism in 
the 1980s.  NFLIS reported that the first confiscation of Butyrylfentanyl occurred in 
March 2014 in Kansas (Prekupec et al., 2017). As of 2015, the DEA attributed 
Butyrylfentanyl to at least 40 deaths (Prekupec et al., 2017). The DEA stated that the 
potency and toxicity of Butyrylfentanyl are unknown due to insufficient scientific data 
(DEA, 2016a). However, the pharma logical profile is similar to that of Fentanyl and 
other fentanyl derivatives. Additionally, the abuse pattern of this substance is related to 
heroin, Fentanyl, and other fentanyl analogs. In May 2016, Butyrylfentanyl temporarily 
placed into the Schedule I category of the controlled substances. The final order stated 
the substance offered no medical value and served as a danger to users and first 
responders due to the clandestine nature of its production (DEA, 2016a). 
Furanylfentanyl 
Furanylfentanyl, a fentanyl analog, was first mentioned in a patent text in 1986 
(Prekupec et al., 2017). There is limited knowledge as to the potency and toxicity of this 
substance due to the lack of human testing. NFLIS first noted Furanylfentanyl in January 
2016 (DEA, 2016e). In the period between January 2016 and May 2016, 80 law 
enforcement reports indicated the confiscation and identification of Furanylfentanyl 
(E.A., 2016e). The DEA identified at least 128 Furanylfentanyl related deaths in 2015 
and 2016. Due to the lack of medicinal value and the potential for addiction and 
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overdose, in September 2016, Furanylfentanyl was temporarily placed into Schedule 1 of 
the schedules of controlled substances (DEA, 2016e). 
Carfentanil 
Carfentanil is a synthetic opioid designed to tranquilize elephants and other large 
mammals (DEA, 2016e). Carfentanil is a derivative of Fentanyl; however, it is 100 times 
more potent than Fentanyl, and 10,000 times more potent than morphine (DEA, 2016e). 
Due to the lack of human testing, experts are unsure of the lethal human dose of 
Carfentanil. In 2015, the United States produced 19 grams of Carfentanil for a legitimate 
purpose (Melendez, 2016). In 2016, the DEA identified one shipment from that contained 
more than 50 times that amount (Melendez, 2016). U.S. Customs and Border Patrol 
reported five Carfentanil seizures between October 22, 2016, and June 27, 2017 (U.S. 
Customs and Border Protection Office of Field Operations, 2017). The amount of 
Carfentanil seized in these shipments totaled nearly 2 kilograms (U.S. Customs and 
Border Protection Office of Field Operations, 2017). 
The DEA reported Carfentanil is typically trafficked from Mexico and China and 
sold directly into the illicit drug market, often through the dark web (Melendez, 2016). 
Like Fentanyl, Carfentanil is cheap to produce and easy to acquire (DEA, 2016e).  The 
potency of the drug allows dealers to mix it with heroin to keep the cost down and make a 
more significant profit (DEA, 2016e).  Notably, because Carfentanil is exceptionally 
potent, fewer quantities are necessary for trafficking purposes. Therefore, it is easier to 
send and disguise through mail channels (DEA, 2016e). 
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The DEA reported overdose rates skyrocketed in August and September 2016. 
The Midwest and Appalachian regions seemed to be hit the hardest (Sanburn, 2016). 
Hamilton County Ohio reported 200 overdoses in seven days in August 2016 (Sanburn, 
2016). The DEA estimated that the Midwest region saw about 300 overdoses in less than 
a month. Tom Synan, the director of the Hamilton County Heroin Coalition, 
hypothesized the Carfentanil originated in China and traveled to Mexico in response to 
online purchases. Mexican drug traffickers then transported the product to the United 
States and distributed it via illicit channels (Sanburn, 2016). 
Misailidi et al. (2017) stated that up until March 2017, Carfentanil was not 
regulated in China; therefore, there was no limitation on the production, manufacturing, 
or sale. Misailidi et al. (2017) explained that Carfentanil is openly marketed on the dark 
web, typically as a "research chemical." In 2016, a dark web search yielded 118 websites 
in which Carfentanil was available to purchase (Misailidi et al., 2017). Melendez (2016) 
quoted one dark web vendor who warned potential consumers of the potency of 
Carfentanil "Again, we can't stress this enough, Carfentanil is meant to be purchased by 
"only" experienced fentanyl users with a high tolerance, this stuff is NO JOKE." 
Cryptomarkets 
Unbeknownst to many, the dark web, aka the deep web, is an online platform that 
anonymizes users. The dark web will enable users to anonymously purchase items such 
as guns, ammunition, etc. using bitcoin. Bitcoin is a digital currency that operates 
independently of a central bank and utilizes various encryption methods to ensure 
anonymity (Yellin et al., n.d.). Gilbert and Dasgupta (2017) defined a crypto market as an 
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online, internet-based platform that allows users to operate under false personas to 
conduct transactions for various information and commodities. The privacy of the dark 
web, coupled with the bitcoin's anonymity, created the ultimate market for drugs. Perhaps 
one of the most popular crypto markets, before its 2013 shutdown, was Silk Road 
(Gilbert & Dasgupta, 2017). Silk Road, created in February 2011, flourished for two 
years before it was eventually shut down as the result of an FBI investigation. Once Silk 
Road was shut down, crypto markets began to multiply due to the potential profit and the 
open market. Gilbert and Dasgupta (2017) estimated in early 2017 about 50 crypto 
markets were in operation. 
Although numerous cryptomarkets popped up after the Silk Road shut down, 
Alphabay appeared to be the most profitable. Like Silk Road, Alphabay was an online 
marketplace, located in the deep web, designed to facilitate anonymous transactions 
between users. According to the FBI, Alphabay became operational in December 2014 
(FBI, 2017). It took several months to gain the trust and support of the dark web 
marketplace; however, within six months, Alphabay was flourishing (FBI, 2017). At the 
time of the shutdown, Alphabay had over 200,000 users, 40,000 venders, and 250,000 
drug products and toxic chemicals listed for sale (FBI, 2017). To put this in comparison, 
in 2013, when Silk Road was shut down, it had about 14,000 listings for illicit drug 
products (FBI, 2017). The number of vendors advertising for heroin and Fentanyl was 
238 and 122, respectively (FBI, 2017). 
Some including the attorney of Dread Pirate Roberts, aka Ross Ulbricht, the 
founder of Silk Road, argued that Silk Road provided a "safe" environment for drug users 
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to purchase products. Essentially, the argument holds that Silk Road eliminated the drug 
dealer/drug user relationship. As a result, drug users were provided an avenue to purchase 
drugs without traveling to a shady area of town, establishing connections with drug 
dealers, etc. However, the counterargument holds, Silk Road and other crypto markets 
result in the "amazon" effect. Primarily, the ease of purchase appeals to consumers. Law 
enforcement professionals argue that many crypto market customers may never have 
purchased a drug if it wasn't for the cloak of anonymity "guaranteed" through TOR and 
bitcoin. 
Barratt et al. (2016) conducted an ethnographic study with 17 individuals who 
reported purchasing drugs on the Silk Road. The results indicated that at least "some" of 
the study population admitted Silk Road was the start of their drug use. One participant 
explained that he had no avenues to purchase drugs before the establishment of the Silk 
Road (Barratt et al., 2016). 14 of the 17 participants indicated an immediate increase in 
drug use, following the first purchase from Silk Road (Barratt et al., 2016). Notably, 
several participants reported their drug use "steadied" after the initial excitement (Barratt 
et al., 2016). Many of the participants reported finding a new crypto market following the 
closure of Silk Road. 
Quintana et al. (2017) conducted a study in 2015, in which they sent four samples, 
marketed in a crypto market on the dark web as heroin to Energy Control for evaluation. 
The results indicated that each of the four samples contained products other than heroin. 
All four of the samples were found to contain Ocfentanil, a synthetic opioid derived from 
Fentanyl. A test conducted using lab rates yielded Ocfentanil is about 2.5 times more 
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potent than Fentanyl and 1,300 times more potent than morphine (Blanckaert, 2017). As 
with other fentanyl analogs, Ocfentanil I dangerously more potent than heroin. 
Products marketed as heroin, which contain fentanyl analogs, are hazardous to 
users due to the increased potency. Proponents of crypto markets argue the substances 
offered are typically pure and potent, as a result of the rating scale. "Dealers" are 
concerned with their rating, so they are sure to be honest about the product they are 
marketing. However, this study demonstrates that substances sold on the dark web may 
not always be pure and could be cut or mixed with other substances. 
Naloxone 
The first part of this literature review was provided to demonstrate the prevalence, 
rapid expansion, and danger of the opioid epidemic in the United States. The remainder 
of this literature review will examine the currently available literature on the use of 
naloxone. The difference between getting an opioid from a trusted source such as a 
doctor and getting an opioid through any variety of illicit channels such as a street dealer 
or dark web can be the difference between life and death. As the number of overdoses 
continues to skyrocket, and China continues to infiltrate the drug market with synthetic 
opioids, the need for naloxone is stronger than ever. 
Substance Abuse and Mental Health Services Administration (SAMHSA) 
published naloxone is an FDA approved medication used to prevent opioid overdoses. 
Amid a drug overdose, naloxone is often used as a last-ditch effort to block the opiate 
receptor sites and ideally stop and reverse the respiratory-damaging effects of an 
overdose (SAMHSA Naloxone, 2016). 
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Fairbairn et al. (2017) explained that there are four naloxone delivery methods 
that are currently on the market. These methods include: intramuscular via vial, 
intramuscular via an auto-injector (Evzio®), multi-step off-label intranasal spray, and a 
single-step nasal spray (Narcan) (Fairbairn et al., 2017). Resnick (2014) quoted a fire 
official who stated, "there is somebody who's on the ground, who's dead, sometimes 
they're blue, sometimes they're black, and you administer this stuff and sometimes in a 
minute or two or three they're actually up and talking to you" (p. 1). 
In 2014, 47,055 fatal drug overdoses occurred in the United States, 61% (28,647) 
were attributed to prescription opioid analgesics and heroin (FDA, 2016). The FDA 
(2016) explained that the pathophysiology and critical response time of an overdose 
attributed to a legally obtained prescription opioid is comparable to an overdose, resulting 
from an illegally obtained opioid. Simplistically speaking, regardless of where/how the 
opiate is obtained, the response to an overdose will be the same. Research shows higher 
doses of opioids can cause respiratory depression to occur, affecting the oxygenation of 
the blood, which can lead to a reduction of oxygen for the brain and the heart (Boyer, 
2012; FDA, 2016). The deprivation of oxygen from the heart and the mind will 
eventually result in death (FDA, 2016). 
In most cases, respiratory depression can take up to 3 hours, and it can be 
reversed until mortality (Boyer, 2012). Naloxone is used in the wake of an overdose to 
reverse respiratory depression by "displacing opioids from the opioid receptor and block 
the binding of the additional opioids for 20 to 90 minutes" (Boyer, 2012). Notably, 
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depending on the amount and type of opiate injected, the user may reenter respiratory 
depression after the application of naloxone. 
Although naloxone is currently the "talk of the town" and is debated, naloxone is 
not new, by any means. In the late 1990s, amidst the "heroin era," syringe needle access 
programs (SNAP) were initiated in cities such as New York to reduce the impact of 
sharing syringes linked to HIV and other infectious disease transmissions. Fairbairn et al. 
(2017) explained community-based programs partnered with SNAP and began dispensing 
naloxone to drug users, specifically those who inject drugs. These programs were found 
to be very successful in reducing heroin-related deaths. 
Walley et al. (2013) conducted a study comparing the opioid overdose death rates 
in communities where overdose education and nasal naloxone distribution (OEND) were 
implemented to communities with no OEND programs. Communities, where OEND was 
implemented, saw a decrease in opioid overdose death rates. Notably, there is a myriad of 
other factors that could have impacted the reduction in opioid overdose deaths. However, 
this study adds support for the importance of community education and the potential 
positive effects of distributing naloxone. 
Fairbairn et al. (2017) stated that in 2010, the United States saw a dramatic 
increase in heroin overdose rates. During the same time, the U.S. saw a decrease in the 
number of opioid prescriptions supplemented by an increase in the production of 
synthetic opioids. Although heroin overdoses are apparent and problematic, the current 
crisis is more complicated than the heroin era of the 1990s. Fentanyl, fentanyl analogs, 
and other clandestinely produced synthetic opioids are flooding the drug marketplace. 
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The potency of these alternative substances has had a devastating effect. Heroin users 
have always "gambled" with the purity/potency factor, which is considered an overdose 
risk; however, synthetic opioids drastically increase the risk of overdose. 
The optimal dosage of naloxone depends on the amount of the substance 
injected/ingested, as well as the potency of the substance. This combination has proven 
extremely problematic in the current drug climate. Recent studies have found that a 
fentanyl overdose may require multiple doses of naloxone to reverse the overdose 
(Somerville et al., 2017; Sutter, Gerona, Davis, Roche, & Colby, 2017; Fairbairn et al., 
2017). This need was demonstrated in British Columbia, Canada, in 2016. According to 
medical professionals and first responders, patients who reported smoking crack-cocaine, 
which was later determined to be furanyl-fentanyl, required notably high doses of 
Naloxone (Klar et al., 2016). Several patients require 3.0 mg of injectable naloxone, 
which is more than seven times the typical dosage of 0.4 mg. (Klar et al., 2016). 
In 2014, the World Health Organization (WHO) suggested that individuals who 
have a strong chance of being present at the time of an opioid overdose should carry 
Naloxone (WHO, 2014). As opioid overdoses continue to ravage the United States, the 
need to educate users and the community on how to react in case of an overdose has 
become increasingly apparent.  It is customary for medical facilities that administer 
opioid medication to carry naloxone (Wheeler et al., 2015). Additionally, ambulances and 
other medical transportation systems are typically equipped with naloxone. However, 
many argue it makes the most sense to provide addicts and family members with 
naloxone, which will allow them to respond quickly in the event of an overdose (Wheeler 
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et al., 2015). From the early 1990s to the present day, we have seen a notable increase in 
the programs designed to educate and equip individuals with the tools to handle an opioid 
overdose effectively (Wheeler et al., 2015).    
The Harm Reduction Coalition (HRC) conducted a study in which they sought to 
identify how many naloxone kits had been distributed as of June 2014 May. They 
contacted, through an online survey, executives of 140 organizations that distribute 
naloxone kits. Such organizations included pharmacies, health care providers, 
rehabilitation facilities, etc. (Wheeler et al., 2015). Wheeler et al. (2015) reported from 
1996 to June 2014; the 136 responding organizations provided 152,283 individuals with 
appropriate training and overdose kits, including naloxone. Of the 136 responding 
agencies, 109 collected overdose metrics; these agencies documented 26,463 overdose 
reversals, 8,000 of which occurred in 2013 (Wheeler et al., 2015). 
The Legal Journey 
Naloxone is characterized as a prescription drug; however, it is not classified as a 
controlled substance (van Dorp et al., 2007). Although classified as a prescription drug, 
naloxone has no potential for abuse and a low overall risk of harm (Davis & Carr, 2017). 
In recent years, both the Federal and State government have pushed to expand access to 
naloxone to equip laypersons better (Davis & Carr, 2017). However, numerous overdoses 
that have resulted in death are often viewed as preventable if naloxone was on hand for 
immediate application (Davis & Carr, 2017). Naloxone can be a potent, lifesaving tool; 
however, it must be administered as soon as possible to avoid permanent cell death and 
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other potential adverse effects (Davis & Carr, 2017). Time is of extreme importance 
when it comes to opioid over-induced respiratory depression (Davis & Carr, 2017). 
Due to the impending clock and the prevalence of overdoses, numerous medical 
health associations advocate for the importance of equipping laypersons and addicts with 
take-home naloxone kits (Davis & Carr, 2017). However, even though naloxone is not a 
controlled substance, it is defined as a prescription substance and, therefore, typically 
requires the prescriber to examine the individual seeking the prescription before writing 
the prescription (Davis & Carr, 2017). Nevertheless, given the current state of the opioid 
epidemic, in recent years,' numerous states have adjusted the stringent guidelines, which 
prevented widespread naloxone distribution. 
Davis & Carr (2017) explained that most states had disregarded the constraints 
which required naloxone to be administered only for use on an individual for which the 
prescribing doctor had an established prescriber-patient relationship. In 44 states, third-
party prescription laws allow naloxone to be prescribed and distributed to any individual 
who may be present at the time of an overdose (Davis & Carr, 2017). Alternative means 
of distribution occur via non-patient specific standing orders (NPS). These orders are 
typically written to allow the dissemination of naloxone to any individual at risk of an 
overdose (Davis & Carr, 2017). NPS orders fall widely under the best judgment of the 
prescriber. Furthermore, in recent years, 32 states have enacted legislation that provides 
naloxone prescribers with criminal immunity for "state law violations to pharmacists that 
dispense naloxone as authorized by the law" (Davis & Carr, 2017, p. 183). Many states 
have removed some of the legal barriers to the prescribing and dispense of naloxone. 
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Good Samaritan Laws 
As mentioned above, time is of the essence when it comes to responding to an 
opioid overdose. With a product such as naloxone available, one may assume that the 
majority of opioid overdoses may be preventable (Banta-Green et al., 2013; Davis, 2017).  
However, often, the individuals who witness the overdose have drug paraphernalia, under 
the influence of an illegal substance, or solely at the wrong place/wrong time and 
concerned about how they may be treated in light of law enforcement intervention 
(Banta-Green et al., 2013; Davis, 2017). These fears have prevented countless individuals 
from contacting the authorities in the wake of an overdose and may have delayed a 
potential lifesaving effort (Banta-Green et al., 2013). 
Based on the information reviewed in July 2017, 40 states and the District of 
Columbia were enacting Good Samaritan legislation (Davis, 2017). Although the inner 
workings of each law differ by state, overall, the legislation is designed to offer 
individuals who in good faith contact authorities in the wake of an overdose, some sort of 
protection. Depending on the state, Good Samaritans may be granted protection from 
drug paraphernalia or illicit substances, as well as protection from probation or parole 
violations, and various other charges. 
Price and Products 
The FDA first approved naloxone in 1971 (Gupta et al., 2016). The rapid and 
widespread increase in opioid overdose led to the formulation of the auto-injector 
formula (Evzio®) (Gupta et al., 2016). The auto-injector formula allowed individuals 
with no medical training an easier route to deliver naloxone. 
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In 2015, the FDA again accelerated the approval process for a nasal-spray product 
designed to deliver naloxone. The nasal-spray, also known as naloxone, was intended to 
reduce the risk of administering naloxone by the untrained professional. As the theory of 
supply and demand would indicate, in recent years, we have seen steep increases in the 
cost of naloxone. Perhaps most significantly, Evzio®, the auto-injector version of 
naloxone, increased from $690.00 in 2014 to $4,500 in 2016 (Gupta et al., 2016). 
Recent data indicate two nasal-spray doses of naloxone costs approximately $178 
for government agencies, first responders, health departments, and other qualifying 
groups when they purchase directly from the manufacturer, law enforcement officer, or 
its authorized distributors (Evzio, 2018). The lack of competition in the marketplace, 
coupled with the growing demand allows retailers to raise prices continually. In recent 
years, states such as California and Vermont have enacted legislation designed to prevent 
unnecessary price gouging (Gupta et al., 2016). 
Childs (2015) listed several roadblocks that law enforcement agencies may face in 
the implementation of naloxone policies. The first and perhaps most notably is the ever-
increasing price of naloxone. The gravity of the potential expenses associated with 
equipping law enforcement with naloxone has resulted in backlash from the law 
enforcement community. Law enforcement agencies maintain that they do not have the 
funding available to implement naloxone programs requiring them to purchase naloxone 
and ensure officers are trained to administer the medication properly. Although there are 
cheaper versions of naloxone available, such as the syringe-based formula, law 
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enforcement officers in individual states are not authorized to administer the medication 
through injection, limiting the purchasing options (Childs, 2015). 
The argument against the price of naloxone has continued to strengthen due to the 
continuous emergence of synthetic opioids. Synthetic opioids such as fentanyl and 
fentanyl analogs have been found to require a more potent dose of naloxone. In the past, 
the starting dosage of naloxone was recommended to be 0.4 mg; however, in recent 
years, it has been recommended to immediately start with a 2.0 mg dose (Prekupec et al., 
2017). Prekupec et al. (2017) stated that there are known cases that have required 10 mg 
to 20 mg doses of naloxone. 
Additional barriers to law enforcement implementation of naloxone policies 
include liability concerns, lack of Good Samaritan laws, and medical doctors who refuse 
to write a standing order for the dispense of the Naloxone (Childs, 2015). Since naloxone 
is a prescription medication, but not a controlled substance, first responders must be 
authorized to carry and administer the drug (BJANTTAC, n.d.). Typically, a licensed 
prescriber can issue a "standing order" to an entire department, which would allow first 
responders to carry and administer Naloxone (BJANTTAC, n.d.). 
Commonly, the law enforcement agency and the collaborating health care agency 
sign a memorandum of agreement to legitimize the relationship (BJANTTAC, n.d.). New 
York was the first state to work directly with the Board of Pharmacy to simplify the 
process and enact legislation that allows law enforcement agencies to purchase naloxone 
directly from a wholesaler, eliminating the need for a prescription and a standing order 
(BJANTTAC, n.d.). In some states, law enforcement agencies have established working 
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relationships with EMT agencies to streamline naloxone training and purchasing 
(BJANTTAC, n.d.). 
Adversaries of Naloxone 
Many adversaries of naloxone distribution programs argue that by distributing 
naloxone kits to addicts, family members, and friends, we are essentially enabling addicts 
to abuse illicit drugs. Seal et al. (2003) conducted a study in which they surveyed a 
population of 82 San Francisco based drug users who reported experiencing at least one 
heroin overdose. An overwhelming 87% of the participants indicated they would be 
inclined to participate in an overdose training program to learn situational awareness and 
receive take-home naloxone (Seal et al., 2003). Thirty-five percent of the respondents 
indicated the distribution of naloxone might allow them to feel more comfortable when 
using heroin and subsequently use higher doses (Seal et al., 2003). However, to date, 
research has not demonstrated that overdose education and naloxone distribution 
programs OEND) lead to an increase in drug use for participants (Doe-Simkins et al., 
2014). 
Seal et al. (2003) found that if provided naloxone, 62% of respondents reported 
they might refrain from calling law enforcement in the event of an overdose. Notably, 
30% of participants indicated they would leave the scene following the application of 
Naloxone (Seal et al., 2003). Due to the potency of many synthetic opioids currently on 
the market, it is essential to monitor an individual following the use of naloxone. In a 
qualitative study designed to gauge officers' perceptions on the overdose epidemic, in 
regard to naloxone, one officer stated: 
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I think it is a 'get out of jail free' card because if you take the naloxone, "Oh, you 
know what? Hey, I screwed up, and I fell off the wagon. Let me just take the naloxone, 
and I'll start over again. It gives them a way out (Green et al., 2013, p. 10). 
Naloxone and Law Enforcement 
As the opioid epidemic continues to worsen and overdoses become increasingly 
prevalent, states have begun developing new initiatives to combat the growing epidemic 
better. Community-based programs have been vital in equipping addicts, friends, and 
family members with opioid overdose training and an overdose prevention kit, including 
naloxone. Since the late 1960s, paramedics have been carrying doses of naloxone to be 
prepared for an overdose call. However, as opioid overdoses continue to increase, many 
states, along with the Federal Government, have stressed the importance of equipping 
other first responders with Naloxone (Davis et al., 2014). Since 2010, the National Drug 
Control Strategy has urged state and local authorities to implement policies that equip 
better officers and first responders with Naloxone (Executive Office of the President of 
the United States, 2016). 
The Federal Government has also implemented several initiatives designed to 
combat the opioid epidemic. The Department of Defense (DOD) has begun to equip first 
responders stationed on military bases with naloxone kits and opioid overdose training 
(Executive Office of the President of the United States, 2016). Since 2013, the 
Department of Veterans Affairs distributed over 45,000 naloxone kits, 39,000 of which 
went to veterans (Executive Office of the President of the United States, 2016). The Food 
and Drug Administration fast-tracked the evaluation process of Narcan®, the nasal spray 
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version of naloxone, to provide first responders and laypersons an alternative to the 
injection route (Executive Office of the President of the United States, 2016). From the 
fourth quarter of 2013 to the second quarter of 2015, we have seen a drastic 1170% jump 
in the pharmacy distribution of Naloxone (Jones et al, 2016). 
Since the release of naloxone in the 1960s, it has been a staple in hospitals, 
paramedic kits, ambulances, and other medical facilities that use prescription opioids 
(Belz et al., 2006).  As the number of opioid overdoses and subsequent fatalities continue 
to increase, the need for law enforcement and EMTs to carry naloxone has become a 
controversial topic (Kitch & Portela, 2016). The debate is especially pertinent in rural 
areas where it may take a more extended period for a paramedic to reach the scene of an 
overdose (Kitch & Portela, 2016).  In contrast, officers or EMTs may be closer in 
proximity and able to respond in a shorter period (Kitch & Portela, 2016).  A study 
conducted in 2006 found that by equipping EMTs with naloxone, the time to reach the 
scene of the overdose would be reduced anywhere between 5.7 and 10.2 minutes (Belz et 
al., 2006).  Belz et al. (2006) highlighted the potential efficiency that could be a result of 
utilizing EMTs to respond to overdose calls, rather than paramedics. 
Kitch and Portela (2016) conducted an observational study examining the officer's 
experiences and outcomes when administering naloxone. The results indicated that within 
48 hours, officers who had received training in overdose identification and naloxone 
application were successful in administering naloxone to four overdose victims. Kitch 
and Portela (2016) explained that although the initial results appeared to be positive, 
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equipping law enforcement with naloxone requires funding, internal agency 
communication, and consistent training. 
As the government continues to encourage law enforcement agencies to equip 
officers with naloxone, adversaries cite potential liability charges as a deterrent factor. 
Davis et al. (2015) stated a review of the available research indicated no cases regarding 
law enforcement and naloxone administration. 
The Danger for Law Enforcement Officers 
In 2010, the Office of National Drug Control Policy (ODNP) stated: "naloxone 
should be in the patrol cars of every law enforcement professional across the nation" (The 
White House, 2013). With that said, each law enforcement agency has the autonomy to 
decide whether to equip officers with naloxone. Paramedics typically administer 
naloxone through injection; however, in 2015, the FDA approved a nasal spray, 
commonly referred to as naloxone. Naloxone allows police officers to deliver potentially 
lifesaving medicine through a nasal spray, subsequently avoiding the potential risk 
associated with needle exposure (Ray et al., 2015). 
Green et al. (2013) conducted a qualitative study examining the officer's attitudes 
toward overdose prevention strategies. Green et al. (2013) found many officers 
considered it part of their job duties to protect the community and ensure public safety; 
however, many of the participants reported concerns regarding the additional 
responsibility of preventing overdoses. Additionally, many participants communicated 
feelings of helplessness due to the lack of treatment options available for addicts (Green 
et al., 2013). On the topic of law enforcement officers carrying naloxone, one supervisor 
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stated, "I know I don't want my officers giving people shots and pills. We get sued for 
enough stuff. Let people with some health training issue that" (Green et al., 2013). 
Summary and Conclusions 
The literature review related to opioid use/abuse and social identity was solely 
focused on law enforcement officers' roles in response to a suspected overdose. Law 
enforcement officers have been tasked to step-up to the front line in the opioid crisis. 
With the shift from prohibition to the implementation of harm reduction and social work 
philosophy, officers had to alter their approach to the law enforcement mission. Multiple 
databases were reviewed on Narcan/naloxone, opioids, and social identity theory as it 
related to law enforcement, precisely their responses. While there was limited research on 
the specific view from the law enforcement officer's perspective, no gaps were found. 
Being tasked with carrying and administering Narcan (naloxone) during a 
suspected opioid overdose, law enforcement officers must negotiate their roles and 
responsibilities during a potentially hostile event. This study focused on examining the 
lived experiences of police officers and their roles during an opioid overdose. Using the 
social identity theory as a lens, we examined how law enforcement officers deal with 
intergroup relationships as well as how they viewed themselves in their new role 
(Ashforth, 2016; White et al., 2002; Stets & Burke, 2000).   
This phenomenological study explored the lived experiences of law enforcement 
offices tasked with carrying and possibly administering anti-opioid medication 
(naloxone), which is a departure from their primary role as law enforcement to a differing 
role as an EMT.  Social identity theory was the framework for understanding and 
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Chapter 3: Research Method 
Introduction 
The following chapter provides a reminder of the studies purpose, the planned 
research design and rationale, the role of the researcher, the planned methodology, and 
any issues of trustworthiness.  As previously stated, the purpose of the research was to 
gain an understanding of the law enforcement officer's perceptions of the mandated 
Narcan/naloxone policy as they negotiate the roles and responsibilities of both law 
enforcement officers and EMTs during a perceived opioid overdose.  This study sought to 
present information regarding the lived experiences Jefferson County law enforcement 
officer faces during an opioid overdose and their unheard perspectives. 
Edmonds and Kennedy (2013) noted that the qualitative method aims to reveal 
and understand phenomena within a particular context without attempting to infer any 
type of causation.  For this qualitative phenomenological study, Colaizzi’s descriptive 
phenomenological method was utilized (Morrow et al., 2015).  Descriptive 
phenomenology reveals the essential structure of the phenomenon being investigated 
(Morrow et al., 2015).  In 1978, Colaizzi developed a seven-step process specifically 
focused to provide rigorous analysis throughout, to remain close to the data (Morrow et 
al., 2015).  Utilized correctly, the results will be a concise yet all-encompassing 
description of the phenomenon being studied, including validation from the participants 
(Morrow et al., 2015).  To achieve the desired results, the process starts with rich first-
person accounts of their experience through face-to-face interviews, as well as other ways 
that includes online interviews, and written narratives.  Additionally, Colaizzi’s 
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descriptive phenomenological method is valuable in areas where existing research is 
limited (Morrow et al., 2015).   
In the case of law enforcement officers’ lived experiences with Narcan/naloxone, 
this approach was employed to address the limited research on the topic, including 
interviews and observations.  Often, qualitative research is used to pave the way for 
future quantitative analysis in which causation may be inferred (Edmonds & Kennedy, 
2013).  Law enforcement officers in Jefferson County, Alabama, have been responding to 
opioid episodes for many years.  Lawmakers instituted a policy that required law 
enforcement officers to carry and employ Narcan/naloxone during perceived opioid 
overdoses.  This research examined the perspectives of law enforcement officers and how 
they view the policy effects on their work identity.  How has the philosophical change 
from enforcement to harm reduction impacted the officer's view of their identity under 
the current mandate?  Social identity theory addresses individuals who categorize 
themselves as part of a group to experience positive emotions (Chattopadhyay & George, 
2001).  As it relates to social identity theory, how is the individual's identity affected by 
the policy changes that require law enforcement officers to carry and administer 
Narcan/naloxone, which has traditionally been a medical-type procedure.  Due to the 
limited amount of available research as it relates to law enforcement officers' perceptions 
of using Narcan/naloxone, this study utilized a qualitative approach to develop a better 
understanding of the topic at hand. 
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Research Design and Rationale 
The research method for this study was Colaizzi’s descriptive phenomenological 
method with thematic-based analysis.  The theory used in this study was social identity 
theory.  Social identity theory addresses individuals who categorize themselves as part of 
a group to experience positive emotions (Chattopadhyay & George, 2001).  Simon and 
Goes (2013) contend that a qualitative study is one in which the researcher collects data 
in the natural setting or environment. The participants had direct and personal experience 
of the studied phenomenon, and I tried to understand how the participant made sense of 
the phenomenon.   
The descriptive tradition of phenomenology originated with the writings of 
Husserl and was further developed by Merleau-Ponty (Sundler et al., 2019).  Husserl 
described lived experiences as a lifeworld approach, which is crucial and is the starting 
point for understanding (Sundler et al., 2019).  Understanding of lived experiences is 
linked to the idea of intentionality of consciousness (how meaning is experienced; 
Sundler et al., 2019).  It is proposed the intentionality of consciousness is directed 
towards something when we experience the phenomenon, it has meaning for the 
individual, can be described and does not require interpretation (Sundler et al., 2019). 
Role of the Researcher 
A significant concern with any study is bias, the potential bias of the researcher. 
As the primary data collector and sole data collecting tool, it was crucial to address the 
potential bias that may have presented itself in the research. Any researcher who can 
identify their personal views and distinguish personal ideologies would be more 
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successful in hearing and digesting the behaviors of the interviewees (Dibley 2011; Fields 
& Kafai, 2009).  Although I have a degree in criminal justice and a background in 
military law enforcement, I did not have any experience with Narcan/naloxone or any 
personal or professional relationships with the proposed participants.  Additionally, there 
were no foreseen conflicts of interest with my work environment or power differentials 
because I did not live or work in Jefferson county.  I also did not provide incentives for 
participants and none were provided.  
Clarification of research bias and detailed and thick description were the 
verification methods used in the study. Clarification of researcher bias was critically 
essential in the proposed research. The reader needs to understand the researcher's 
position concerning the topic (Spiers et al., 2018). I am a former military law 
enforcement member, however, never civilian law enforcement.  I had no previous 
experiences with drug use, opioids, heroin, or Narcan/naloxone.  I was conscious of his 
experiences and bracketed them accordingly.  
When researching the lived experiences, openness to the lifeworld and the 
phenomenon must be emphasized.  Therefore, I maintained the attitude I do not know the 
participant’s experience.  Also, I am trying to understand the phenomenon in a new light 
as to see things previously unseen.  This was accomplished by setting aside previous 
experiences, assumptions and continuously questioning.  Much like bracketing, I 
refrained from positing my sense of reality onto the participant's experiences (Sundler et 
al., 2019; Van Manen, 2017).  I also recognized his personal beliefs, theories, or 
assumptions as to not restrict one’s openness.  Any pre-understanding or prejudice in 
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interpreting the studied phenomenon, could have led to a description of the researcher’s 
own experiences, instead of the participants’ experiences (Sundler et al., 2019).   
Methodology 
The research design for this study was Colaizzi’s descriptive phenomenological 
method with thematic-based analysis.  Thematic-based analysis is a method of analyzing 
qualitative data, usually applied to text such as interview transcripts.  The process for this 
study included collecting primary data through one-on-one interviews of law enforcement 
offices, who have experience with both Narcan/naloxone and opioid overdose response.  
The focus was on the officer's description, perception, and lived experiences, which 
distinguishes it from a case study design (Bernard, 2013; Stake, 2006; Yin, 2017). Also, 
the design was not ethnographic since data collected was not reliant on a specific period 
(Sangasubana, 2011).  
It was not a grounded study because the purpose was not related to generating a 
new model or theory. Finally, the study was not narrative since the goal was to 
understand and describe a group of law enforcement officers' perceptions and 
understanding of their experiences with Narcan/naloxone.  Narrative research focuses on 
one or two individuals and re-telling their stories. Phenomenological inquiry uses an 
open-ended, emergent design, that document details and events that chronicle the law 
enforcement officer’s personal experiences in the field (Roulston, 2011).  Narratives 
accounts offered by the sample of law enforcement officers were audio and video 
recorded digitally and hand-transcribed documenting the exact words for contextual 
perspective later in the analysis (Al-Yateem, 2012).  Data was be collected through semi-
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structured interviews, and participants met in a neutral location such as a public library or 
community meeting room.  The selection provided a modicum of privacy and comfort to 
the individual (Jacob & Furgerson, 2012; Mikėnė et al., 2013).  The focus of this study 
was on an intense and dynamic situation.  Using a descriptive phenomenological 
approach, I was able to provide firsthand depictions of these events described by the 
individuals who were directly involved.  This level of detail and exposure should help 
others comprehend how this phenomenon has affected the lives of the people who face 
the opioid crisis daily. 
Participants 
The target population for this study was law enforcement officers in Jefferson 
County, Alabama, who are mandated to carry and administer naloxone as part of their 
routine duties.  All participants were current/active law enforcement offices in Jefferson 
County, Alabama.  All participants had firsthand knowledge and experience with 
Narcan/naloxone.  All participants had firsthand experience with an opioid response. 
Jefferson County, Alabama is the densest populated county in the state of 
Alabama and includes the state capitol city of Birmingham.  The area is approximately 
1,124 miles with a population of 659,197 personnel (Jefferson County Commission, 
2019).  The study used participants from the different Jefferson County law enforcement 
agencies, urban or rural, who implemented the harm reduction policy that requires their 
officers to carry and administer Narcan/naloxone.  
The phenomenological approach only required a small group of participants who 
meet the study parameters.  However, the sampling strategy was attaining enough 
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participation to achieve data saturation.  Fusch and Ness (2015) noted data saturation 
occurs once the researcher can no longer obtain new information or when the data 
collected could replicate the study without further coding.  Conversely, larger sample size 
does not automatically ensure data saturation will be reached (Burmeister & Aitken, 
2012).  The sample size was instrumental, and it is essential to be mindful, and the 
selection of willing participants helps best fit the study's goals.  For this study, I asked for 
volunteers among the Jefferson county law enforcement population. I collected data until 
saturation was reached. 
Purposeful sampling was employed to ensure participants had at least one year 
police experience, and they had administered Narcan/naloxone at least once during an 
actual opioid overdose event.  Purposeful sampling occurs when the researcher 
deliberately selects participants to provide quality information that cannot be gained from 
other sources (Maxwell, 2005).  Before officially contacting the police officials through 
their Public Relations Manager/Public Information Officer, I worked through the IRB 
approval process.  Official contact did not occur until after I received IRB board approval 
#09-24-20-0444856. I used the supplied recruitment flyer in Attachment A that provided 
a brief overview of the study and contact information.  The goal was to get the flyer 
disseminated to the law enforcement officers in the different Jefferson county 
departments.  Including my contact information eliminated the need for management 




It was necessary to approach each participant as a single entity while remaining 
true to the overarching purpose of the study.  The plan for the study was to conduct semi-
structured interviews with each voluntary participant.  In order to accomplish this, I 
employed an interview guide to ensure the same questions were asked of each participant.  
An interview guide is a list of questions created by the researcher based on the research 
question (McNamara, 2009; Patton, 2003).  The participant guided the interview as they 
provided their inputs, passion, and experiences.  Follow-up questions were asked as well 
as clarifying questions regarding participant’s opinions and experiences.   
Primarily, data collection was supposed to be face to face interviews; however, 
with the states Coivd-19 protocols including the required social distancing rules, video 
conferencing and telephone interviews were utilized (i.e., Skype, FaceTime, Zoom, etc.).  
Additionally, I used a variety of mediums including a laptop, iPad, paper, and writing 
utensils for notetaking.  I tried to ensure the participant and location were comfortable, 
and I made myself available to meet the participants' schedules. Because my participant 
pool was all law enforcement officers, the plan was to meet during non-work hours in a 
neutral location (library, community meeting room, etc.). I tried to ensure the participant 
and location are comfortable, and I made myself available to meet the participants' 
schedules. 
At the conclusion of the interview, I thanked each participant for their valuable 
insights and openness.  I reiterated the terms of informed consent and reassure them that 
all transcripts and recordings of the interview would be destroyed when no longer 
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needed.  Once the participant departed, I made time to complete my field notes regarding 
the individual’s demeanor or other observations. 
Procedure/Data Analysis 
As the sole data collector, I was responsible for collecting and maintaining data 
throughout the study.  In qualitative research, the researcher must protect the participants' 
identity.  For this study, I made sure the participant’s identity remained confidential. No 
identities were disclosed and codes to identify each participant were used (i.e., Participant 
1, Participant 2, etc.).  Before contact was made with the participants, the final step was 
approval from the IRB. 
Before all interviews, participants received either an email of text message with a 
consent form and confirmation of the date, time, and location.  They were reminded their 
participation was voluntary, and they could terminate the interview at any time.  All 
participants completed the consent form before the interview, and we discussed any 
questions or concerns related to the interview process.  Before any recording, I obtained 
verbal permission from each participant to ensure they are aware and comfortable using 
any recording devices (Hancock & Algozzine, 2017).  Stuckey (2014) noted that by 
recording the interview, the researcher is free to fully concentrate on the conversation and 
responses of the interviewee rather than capture any notes.  Each interview was recorded 
using one or more of the following devices, a Livescribe Echo smartpen, iPhone, or 
screen captured.  Interviews were transcribed by me in their entirety, making note of tone 
and inflection to garner the full picture.  After each the interview was complete, and the 




The process of coding allows the researcher to break up the data into small 
portions and then reassemble it to express the narrative (Saldana, 2016; Stuckey, 2015). I 
will use descriptive coding to assign labels to the data in order to summarize in a word or 
short phrase (Saldana, 2016).  The premise of coding allows the researcher to connect 
similar data for interpretation and association (Chowdhury, 2015; Saldana, 2016; 
Stuckey, 2015). Descriptive coding is appropriate for most qualitative studies and is well 
suited for beginning qualitative researchers (Saldana, 2016).  The data included in all 
coding was interview transcripts and field notes as applicable.  Analyzing that data from 
each interview informed the questions for the following interview.  Part of the coding 
process was identifying nodes and developing themes from each participant interview. 
Trustworthiness 
This study relies fully on the participant interviews and their truthfulness is 
paramount.  Although I was not able to control the participant’s honesty, I ensured the 
questions and atmosphere of the interview location lends itself to a quality interview.  To 
ensure the collected data was quality, I tried to build trustworthiness with all participants.  
Anney (2014) stated that trustworthiness includes four criteria: credibility, transferability, 
dependability, and conformability.  
To build credibility, I maintained contact with each participant and completed 
member checks to ensure their portion is believable and accurate.  Member checks 
allowed the participant to review a summary of their interview, granting them the 
opportunity to make comments or corrections.  I provide rich, thick descriptions 
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developed from the participant’s own words.  Triangulation was not used, as there will 
not be any organizational information available.   
Transferability refers to usefulness and relevance of the finding in a study and 
there is no guarantee no matter the method used.  In qualitative studies, it is challenging 
to achieve transferability, but not impossible.  However, providing detailed descriptions 
and quotes helps build towards transferability (Sundler et al., 2019).  Additionally, all 
interviews were recorded to ensure verbatim transcripts were available.   
Dependability requires the researcher to make their data available for other 
researchers (Cope, 2014). When another researcher can replicate the findings and use 
them in a similar setting, the study is considered dependable.  I created a USB flash drive 
to keep track of my notes, documents, and other records.  Confirmability is similar to 
dependability as it relates to audits, documentation, and notes.  Cope (2014) noted that 
researchers could enhance conformability by ensuring that the collected data is only the 
participants' responses and not the researcher.  This leads to reflexivity, which 
acknowledges the researcher as a participant in the process and not just an 
outsider/observer (McNair et al., 2008; Spence, 2016).  As the sole data collector, I 
maintained a journal to note my thoughts, observations, and interpretations.  I made these 
entries after the completion of the participant interviews.   
Verification of Findings 
The proposed research findings were verified instead of validated.  The 
verification of findings helps maintain the spirit of a qualitative study (Spiers et al., 
2018). The verification process involved a minimum of two (of the eight) recommended 
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steps. The final form of verification involved detailed, thick descriptions.  The purpose of 
a detailed description allowed the reader to transfer information to other settings and to 
determine whether the findings can be transferred based on shared characteristics (Spiers 
et al., 2018). 
Summary 
The opioid crisis has caused devastation across the country and around the world. 
Federal, state, and local officials have implemented policies to combat the ever-growing 
epidemic.  As it relates to law enforcement's roles, desperation for action has trumped 
accurate, evidence-based research on the results.  Advocates of the harm reduction policy 
argue there is no detriment equipping law enforcement officers with naloxone. 
Hyperbolic statements like "it saves lives" and "if it saves one life, it is worth it" are 
made in support of this position. However, counterarguments can be made as to why law 
enforcement officers are tasked to carry Narcan/naloxone and not epi-pens.   
Unfortunately, the opioid crisis is not showing signs of improvement, and the role 
of law enforcement will likely continue to expand.  To date, research has not addressed 
law enforcement's perceptions of this role change.  More specifically, this study sought to 
add to the limited research regarding law enforcement officer's perceptions of carrying 
and administering anti-opioid medications.  A significant amount of information 
regarding opioids, pain reduction, and naloxone is discussed. The focus of the study was 
the perceptions of the law enforcement officers who are tasked to carry and administer 
the anti-opioid medication Narcan/naloxone. 
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This qualitative research provided a view into the officer's day-to-day experiences 
with Narcan/naloxone and opioid responses.  The data collected garnered a better 
understanding of the policy change and how it affects the participants.  The result could 
aid law enforcement officials and potentially alter their approach to drafting and 
implementing future anti-opioid policies.  Additionally, officers’ that support this 
initiative can produce a positive social change through officers making more 
compassionate and appropriate decisions by understanding their direct impact on the lives 




Chapter 4: Results 
Introduction 
This qualitative study was designed to examine police officers' lived experiences 
and their roles during an opioid overdose.  In this chapter, I will present my findings with 
a strong emphasis on the participants' direct quotes.  This method will allow the true 
voice of the participant to resonate.  The data collected in this study was derived from 
semistructured interviews with each participant.  The findings presented in this chapter 
are solely based on my analysis of the interview transcripts.  To ensure each research 
question was addressed, I created an interview guide that helped me focus on the research 
question.  Having the interview guide as support allowed the interview to proceed 
organically.  The interview guide helped keep the conversation on track when the 
conversation required guidance.  However, all the interviews flowed naturally and 
covered the research question with minimum probing.  My knowledge and interest in the 
topic along with, the participants' candor and passion for their job, allowed for a natural 
and thorough discussion.  This study's sample size consisted of 12 law enforcement 
officers, with varying degrees of experience, from Jefferson County, Alabama.  
Setting 
All 12 participants were interviewed remotely due to the state-wide safer at home 
order issued by the governor and social distancing requirements.  Five participants were 
interviewed using the Zoom video conferencing application, the remaining seven 
completed telephone interviews because of multiple reasons including no computer 
access to zero desire to use the Zoom application.  The individuals who agreed to 
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participate via Zoom were sent a meeting notification that included a hyperlink for the 
agreed date and time.  The remaining seven were contacted via text message to 
coordinate a meeting time.  Each participant freely selected their interview location, and I 
explained the process would take approximately 1 hour, and it would be best if they were 
alone.  After introductions, I reminded each participant that they were not required to 
participate, and they could stop the interview at any time.  I asked if they reviewed the 
consent form, and I made a specific point to remind each participant the interview was 
voluntary. Their identity would be kept confidential. If needed, they could contact the 24-
hour crisis referral service listed on the consent form.  Once they acknowledged these 
things, I asked if they could verbally consent, all 12 verbally consented.  Ten of the 
participants completed their interviews at home; one completed his interview in his 
vehicle, and one spoke with me in a work conference room to ensure a quality Wi-Fi 
connection.   
The methodology employed was Colaizzi's descriptive phenomenological method 
with thematic-based analysis.  In order to examine the topic, the following research 
question was created:  
Research Question 1: How do law enforcement officers, who are mandated by 
policy to carry and administer naloxone, perceive this policy change as it relates to their 
day-to-day work identity? 
Demographics 
The sample in this study was comprised of law enforcement officers with 
experience ranging between 5 years and 22 years in law enforcement.  There were 12 
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volunteer participants, all participants had been certified to carry Narcan/naloxone for a 
minimum of 1 year.  All participants had deployed Narcan/naloxone in a real-life 
situation at least one time.  These participants were all active officers from Jefferson 
County, Alabama, with firsthand knowledge and experience with multiple opioid 
responses.  Table 1 gives a brief description of the 12 individuals who participated in my 
research project.  Participants are identified with the pseudonym of participant followed 
by the numerals that randomly indicate the number of participants. 
Table 1  
 
Participant Demographics and Characteristics 










Participant 1 Male White Married 5 2 
Participant 2 Male White  Married 22 4 
Participant 3 Male White  Married 15 4 
Participant 4 Male White  Married 10 3 
Participant 5 Male White  Married 8 2 
Participant 6 Female White  Married 5 2 
Participant 7 Male White  Married 5 2 
Participant 8 Male African 
American 
Married 11 4 
Participant 9 Male Latino Married 6 1 
Participant 10 Female White  Married 5 2 
Participant 11 Male White  Married 7 4 




Of the 12 individuals who agreed to complete the interview, seven were White 
males, two were White females, two were Latino males, and one was an African 
American male.  Of the 12 participants, 10 were still on active patrol, one was a patrol 
supervisor, and one was now working in the evidence room.  The participants in this 
study were chosen based on their experience level.  Purposeful sampling was employed 
to ensure each participant had an experience related to the research topic.  All 12 
participants completed the interview without incident.   
Data Collection 
The data collection consisted of one-on-one interviews with each participant, five 
via the Zoom video conferencing application and seven over the phone.  All the 
participants were law enforcement officers from Jefferson County, Alabama.  Once an 
officer was selected to participate, they were contacted via email or text message to 
schedule an interview time and date.  All participants were asked to choose the interview 
date and time; their location was of their choosing.  The interviews lasted a minimum of 
38 minutes to nearly 90 minutes.  After the interview, I immediately summarized what I 
deemed key points, reviewed notable statements, and noted any pertinent observations.  
All the participant interviews were transcribed using Otter.ai, a speech to text 
transcription application.  At a later date, the transcribed interviews were reviewed by 
me, and I corrected any transcription errors manually.  Each Zoom interview was a video 
teleconference; recording started once the participant gave their consent to record.  The 
phone interviews were recorded via Otter.ai.  I repeated the same process depending on 
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the interview style.  There were no notable situations or mishaps which would have 
altered the data collection process.   
Data Analysis 
Before the interview, I provided a brief overview of the research and the purpose 
of the study.  During the interview, I wrote down key terms and notable content; the 
interview was recorded entirely once consent was given and later transcribed.  
Immediately following each interview, I drafted a summary of the meeting, including my 
reactions, key moments, any notable body language, etc.   
One of the more rigorous parts of qualitative research is developing themes.  The 
first step is to become well acquainted with each transcript.  To do so, listened and 
watched each interview, ensuring the transcription was 100 percent accurate.  During my 
reviews, I would highlight or note any memorable statement or comments that caught my 
attention.  This process helped me develop a deep understanding of each transcript, and I 
referred to any notes related to that interview.  This process allowed me to develop a 
deeper association between the conversational cues and behaviors I noted and the 
transcript's verbiage.   
To develop the themes unique to the research question, I read the section of the 
transcript related to the same interview question numerous times to identify repetitive 
words, themes, comments, etc.  This process was repeated for each interview question.  
Although each participant spoke about a different experience and provided their 
individual opinions, there were clear and decisive similarities between their experiences 
and thought process.  Analyzing these experiences allowed for the creation of 
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overarching themes, consistent throughout the interview transcripts.  These themes are 
explored at a deeper level in the forthcoming section.  The identified themes include duty 
to serve, saving life, job hazard, and frustration. 
Evidence of Trustworthiness 
Anney (2014) noted trustworthiness includes four criteria: credibility, 
transferability, dependability, and conformability.  I established credibility by 
maintaining contact and implementing member checks with all participants.  At the 
conclusion of each interview, I informed the participants they would receive a transcribed 
summary of the interview.  I asked them to review the document and ensure the 
information contained accurately reflects their thoughts, ideas, and opinions.  Each 
participant was sent an email, and all replied with not issues or corrections.  Additionally, 
I ensured the participant had my contact information. 
Transferability allows other researchers and readers the information on the study 
process to allow the study to be duplicated.  To achieve this, I provided detailed 
descriptions of my process, direct quotes from the participants, and the research 
methodology (Sundler et al., 2019).  Additionally, all interviews were recorded to ensure 
verbatim transcripts are available. 
Cope (2014) noted dependability requires the researcher to make their data 
available for other researchers.  For this, all the related data for this study is saved on a 
secure drive. Any manually generated notes were inserted into the transcript document 
and transferred to the secure drive.  Additionally, researchers could enhance 
conformability by ensuring that the collected data is only the participants' responses and 
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not the researcher (Cope, 2014).  Reflexivity acknowledges me, the researcher, as a 
participant in the process (McNair et al., 2008; Spence, 2016).   
To achieve conformability, eliminate personal feelings, and ensure accurate data 
collection, I conduct semi-structured interviews using an interview guide.   The 
researcher created the interview guide questions based on the research question 
(McNamara, 2009; Patton, 2003).  Employing the interview guide allowed me to guide 
each interview while allowing the conversation to flow naturally. 
Results 
This study was developed to examine police officers' lived experiences and their 
roles during an opioid overdose.  The interview framework was developed to create a 
conversational approach to each participant interview and establish a positive rapport.  
The interview guide's questions allowed me to establish a rapport while capturing 
important data on the law enforcement officer as it relates to their path into the career 
field, their view of the job overall, and their normal activities.  These questions laid the 
groundwork for capturing their lived experiences and perceived role during an opioid 
overdose.  The goal was to identify any underlying feelings of loss of importance as law 
enforcement officers are asked to perform non-police duties.  Understanding the 
participant's view provides insight into their social identity and belonging. The 
participant interviews, conversational cues, and observation made during the process 
yielded the following themes: duty to serve, saving life, job hazard, and frustration.  






Theme Participant Text Segment 
Duty to Serve P1, P2, P3, P4, 
P5, P8, P10, P11 
Respectable; Honorable; Always wanted to be a 
police officer; Always dream of being a cop; I 
followed in my Father’s footsteps; I wanted to be 
like my father’s friend who I would see in his police 
uniform; My father retired from this department; 
Great job with a lot of freedom; I love being a 
police officer because of the freedom; I dreamed of 
being in the military or being a police officer; I felt 
being on the police force was a great thing 
 
P1, P2, P3, P4, 
P5, P6, P8, P9, 
P10, P12 
Only supervisors were allowed to carry Narcan and 
they offered me the opportunity to carry; Only 
sergeants carry, and they asked me; I was not a 
supervisor but the gave it to me; I was the only 
female in the training class; I was proud to be 
nominated for the class; I wanted the opportunity; I 
carry for my K9; I am the only female on my shift; 
It looks good on me to carry 
 
P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P10, P11, 
P12 
 
It’s just another tool in the toolbox; It is a good 
tool; It is a great tool; It is another tool in the 
toolbox; It is a valuable tool; It is an unbelievable 
tool 
P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P10, P11, 
P12 
 
I like helping people, I always want to help people, 
I am out here to help people, I just want to help 
where I can,  
P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P12 
 




Theme Participant Text Segment 
Saving Life P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P10, P11 
 
It is simple to use; Narcan is simple; It’s really easy 
to use 
P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P10, P11 
The fire department/EMT taught the class; The 
health department came in and trained us; It was 
just like CPR training; We do our refresher training 
with our CPR class 
 
P1, P2, P3, P4, 
P5, P7, P8, P9, 
P10, P11 
 
The training was really good; The training was 
great; The training put me at ease; It was just like 
the training 
Job Hazard P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P10, P11, 
P12 
 
You have to be careful once you give them the 
Narcan, they usually come up fighting; They are 
combative once they get narcanned; They don’t 
know what happened, so they come up swinging 
P1, P2, P3, P4, 
P5, P6, P7, P8, 
P9, P10, P11, 
P12 
Sometimes you are the only person on scene and it 
could be two or three people around; Did I miss 
something; I was the only officer on scene; Most 
times on Narcan calls the individual is not alone; 
Usually they have buddies with them so you have to 
be careful; I’ve seen junior officers rush into the 
scene ignoring all their safety procedures; The 
junior officers are so excited to have Narcan, the 
blow into the room so they can do what they were 
trained for 
 
Frustration P1, P2, P3, P6, 
P7, P8, P9, P10, 
P12 
I feel like we go to the same houses every other 
weekend; It seems like we are narcanning the same 
people all the time; I get angry when I see someone 
fighting for their life and this jughead is shooting 
up; They act like it is no big deal and say they will 
just do it again;  
 
 P1, P2, P3, P5, 
P6, P7, P8, P9, 
P10, P11, P12 
Some folks get angry when you give them Narcan; 
The guy was mad I ruined his high; We had to force 
them to go to the hospital; We have to force them to 
get in the ambulance; We have to force them to go 
with EMT;  
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Additionally, there were notable comments made that did not fit under the 
aforementioned themes. 
Duty to Serve 
All 12 participants viewed their law enforcement career as respectable, which 
allowed them to make a positive difference in the community they serve.  One participant 
noted he had drawings from grade school depicting himself as a police officer.  Another 
participant noted, his father was a police officer, and he was serving in the department his 
father retired from.  Nine of the participants pursued careers other than law enforcement 
before joining the force.  Six of the participants stated, they considered joining the 
military and four served in the Armed Forces before getting into law enforcement.  All 
twelve participants indicated they agreed with the police to carry Narcan/naloxone, 
however, one noted he was initially hesitant.  He stated, “I saw the medics give a guy 
overdosing a shot and I thought that was going to be on me now, I didn’t want to do it.” 
Each specifically noted it was not mandatory for them by the policy; they were 
asked and agreed.  Several participants reiterated, "We actually don't have any type of 
requirement to carry”.  One participant specifically noted, “I look at it as it looks good on 
me, and I like helping people." Two of the more junior officers noted they were asked to 
carry Narcan when the shift supervisors and sergeants were only carrying it.  One 
participant stated, "Our shift didn't have a supervisor, and they asked me because I had 
the most experience." Additionally, ten of the 12 participants stated they're just trying to 
keep people safe. All participants maintained an overall view that Narcan/naloxone is just 
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another tool in their toolbox that allows them to help people, and helping people is their 
job. 
Saving Life 
All participants were asked their training requirements and their thoughts on 
administering Narcan/naloxone as a law enforcement officer.  All eleven of the twelve 
participants stated the use of Narcan is simple.  The fire department trainers trained all 
but one of the participants. One participant noted, the Narcan was demonstrated by one of 
his fellow officers at roll call and they were given written instructions that appeared to be 
copied from the Narcan container.  The other 11 participants completed initial training, 
which consisted of an eight-hour course.  Part of the class included PowerPoint slides 
explaining what Narcan is, how it works, and how to administer the drug correctly.  The 
final portion is a practical application on a CPR-type dummy.   
One participant noted the importance of application speed.  He stated, "I learned 
the hard way not to "slam it" if you do, they will vomit all over the place." Another 
participant noted, "you are supposed to administer 50/50; I thought I did it wrong my first 
time because I gave her one-fifth in one nostril and the rest in the other." “One participant 
stated, “it took me what seemed like a long time to actually give the Narcan my first time, 
I was so nervous that I had to read the instruction twice before I help her.”  Eleven of the 
twelve participants noted annual training/certification is completed in conjunction with 
CPR training/certification.  All participants also noted, the fire department and EMTs are 
routinely dispatched first and often are on scene first.  One participant noted, he was 
shocked he got to the scene first.  In case, law enforcement does arrive on the scene first, 
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the individual is turned over to fire/EMT for further treatment and transfer to a medical 
facility.  One participant stated: 
When we started carrying Narcan, our role changed; now, we are a provider.  It is 
our responsibility to try to get there as soon as possible to provide this medical 
assistance to this person in an attempt to save their life. 
This officer noted that the policy changed to allow an officer to run "code" during 
medical assistance call once officers were equipped with Narcan/naloxone. "Code is 
running lights and sirens." Prior to carrying Narcan, law enforcement officers were not 
allowed to run code to medical assistance calls.   
Job Hazard 
Each participant was asked if they had any fear or concerns with public backlash 
if something went wrong after administering Narcan.  Three of the twelve participants 
stated, no matter what happens, they will be viewed negatively.  One participant stated, 
"if you give someone Narcan and they die, they were dead anyway, you just sprayed 
liquid in their nose, so any anger is misplaced." Eight of the twelve participants were 
more concerned with the individual being combative after being "Narcanned."  Several of 
the participants noted, some individuals have no idea what is happening, and they come 
up swinging.  One participant stated, he is always thinking, "did I miss something" with 
concern for his surroundings.  During his first Narcan application, one participant noted 
he was the only officer at the scene, and the overdose victim was lying on the floor, and 
his friend was watching.  With that visual in mind, another participant stated: 
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My only concern is the more junior officers are more worried about administering 
Narcan, and they are not thinking about making the area safe, the scene safe.  
Chances are they have friends with them who are not happy with your presence, 
but you're more worried about getting their buddy some Narcan. 
This participant further explained he feels a change with the younger officers.  He noted: 
I've seen and heard junior officers when they hear that overdose call; they get 
there as fast as they can, they ignore all their safety procedures, and they blow 
into the house and run-up to this unconscious person and pop that Narcan as fast 
as they can because they want to help this person.  They want to use this Narcan; 
they want to do what they're supposed to do, what they trained for.  But they 
ignored every safety procedure, every officer safety procedure on the way there.   
He stated he had not seen this from a senior officer standpoint, just the junior officers.   
They are excited about having the Narcan, and they get a call for medical 
assistance; they run code and blow into the room and hit the individual with the 
Narcan because that is what they have trained to do. 
Frustration 
Ten of the twelve participants expressed a feeling of frustration as it relates to 
repeat responses to chronic users.  One participant noted on one of his earliest responses 
to a Narcan call, the overdosed individual came back and was angry they had ruined his 
high.  The officer went on to state that 15 minutes later, he had to assist the fire 
department with a dying cancer patient.  He stated, "here she is fighting and doing 
everything she can to live, and I was like, man, we got this jughead over here shooting up 
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and don't give a crap about his life." He further noted, it took some time for him to adjust 
to situations like this.  Another participant noted on his second Narcan experience, it 
made him mad, stating: 
The guy overdosed, we went into his house, we gave him Narcan, and he woke up 
and did the same old stuff.  He didn't want to go to the hospital; we had to force 
him to go to the hospital.  I would usually follow up with these people at the 
hospital 30 minutes later, just to chit-chat because they can't go anywhere.  He 
literally looked at me, and he was like, man, this ain't no big deal, I'll overdose 
again, you should have let me die. 
The officer told the individual it is his job to help; it is his job to save his life.  The 
individual stated, "I'm gonna do what I do no matter what you do, you can save me every 
day, and the following day, I'm gonna use heroin again." Another participant noted he is 
"50/50" on the fence about carrying Narcan/naloxone, stating: 
If I wanted, I could give it back right now, but I've seen drug use in my family, 
and I try to give a pep talk or point you in the right direction, but if they don't 
want to stop, it is the same with alcoholics, it is the same with people speeding up, 
and down the street, you can give as many tickets as you want, but some people 
they just really don't care, they just keep doing it. 
Another officer stated: 
Part of the job of being a police officer is helping people in situations of need, but 
I learned, and you know I have family members who are addicts, you're never 
going to help someone until they want help.  Parents can spend thousands of 
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dollars sending their kids to and relatives to rehab, but if that person doesn't want 
it, it's never gonna happen.  Unfortunately, a lot of times, it is necessary for them 
to go to jail because a judge can order rehab, a judge has the power to mandate 
things a police officer can't.  Basically, do you want prison, or will you submit to 
rehab. 
Summary 
The research quest in this study yielded an array of responses supporting law 
enforcement officers. Overall, the participants hold a strong sense of duty to serve, do 
whatever it takes to help people, and keep them safe.  Universally the participants believe 
Narcan is a valuable tool that saves lives, and all carry Narcan by choice, not mandate.  
The more senior officers have a growing concern for job hazards, with the focus 
seemingly shifting from officer safety to Narcan deployment.  With the number of repeat 
users, there is a growing level of frustration among all the participants.  However, having 
a firm belief in their immediate leadership and trust that the decisions being made are 
best for the department and community.  Chapter 5 provides a review of the study results, 







The purpose of this study was to obtain the firsthand experiences of law 
enforcement officers who are required to carry and employ Narcan/naloxone during a 
perceived opioid overdose.  I hoped to provide the participating officers the opportunity 
to share their stories and experiences.  The study examined the negotiation between the 
primary roles of the law enforcement officer and assumed the posture of a medical 
technician when responding to an opioid overdose.  This chapter includes a discussion of 
all the major findings. 
Interpretation of the Findings 
While each officer's personal experiences, perceptions, and professional careers 
differ, each of the four identified themes applied to each officer's experiences.  
Additionally, the identified themes go beyond the deployment aspects of their 
Narcan/naloxone experiences. Still, they expose the deep dedication to the law 
enforcement officer's role and true concern for community safety.  Responding to an 
opioid overdose call is a very dangerous scene for the responding officer, and they must 
switch from their natural state and perform a potentially life-saving procedure.  During 
Narcan/naloxone's application, when the officer is on the scene, it is challenging, if not 
impossible, for them to maintain a posture of guardian/protector.  Although the 
application of Narcan is simple, it requires a focus on the downed individual, and the 
officer is vulnerable.  An officer on patrol is normally alone; all the participants patrolled 
alone except the canine officer, who had a patrol dog.  Nevertheless, all participants 
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conveyed a strong sense of duty and a desire to serve with a seeming acceptance of the 
dangers. 
Duty to Serve 
The study concluded that each officer interviewed believed they have a duty to 
serve.  When asked their thoughts on the requirement for law enforcement officers to 
carry Narcan, they all had a similar response.  First, there is no organizational 
requirement for an officer to carry Narcan, it is offered to select officers, and all 12 
participants had agreed to carry Narcan.  Secondly, each participant conveyed in their 
own words a desire to be of service to the community.  Purviance et al. (2017) conducted 
a study of law enforcement officers' attitude towards Naloxone training, noting the results 
showed law enforcement officers were receptive.  Smyser & Lubin (2017) noted in their 
study Pennsylvania police chiefs either agreed or strongly agreed to the benefits of the 
Naloxone programs.  There is a general acceptance of Narcan/naloxone training and use 
within the law enforcement community in both these studies.  Nationwide, the opinions 
towards drug users, the legal policy, treatment options vary; however, the availability is 
viewed as a benefit. 
Saving Life 
Although the 12 participating officers are not from the same department, 11 of the 
12 received initial training from fire department personnel.  The training was described 
using words like easy, straightforward, and thorough.  All recertification training was 
held in conjunction with the CPR training.  Only one of the participating officers stated 
he was given a demonstration of the Narcan during roll call.  All officers, during their 
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interviews, described Narcan as a tool.  Eleven of the 12 participants felt prepared and 
capable during their first Narcan deployment.  One participant did note his hesitation 
during the first application. 
Much of the literature on this subject conveys the same idea, Narcan is a tool, 
easy to use, and officers will be trained hand-in-hand with CPR training (Kenyon, 2018).  
Ray et al. (2015) also conducted a study that gauged law enforcement officers' attitudes 
towards naloxone training (intranasal).  The results of this study showed the training was 
not difficult, and the properly trained officers felt using intranasal naloxone would be 
relatively simple.  
Job Hazard 
Each participant was asked what reservations if any, they had about administering 
Narcan/naloxone.  Eleven of the 12 participants clearly stated they did not have any 
reservations.  One participant, who was a patrol supervisor, stated concern for junior 
officers.  When asked about reservations due to public backlash, they all stated they did 
not have any; they universally noted that they would be painted in a negative light no 
matter the interaction with the public.  Six of the participating officers noted various 
degrees of social media backlash when the department announced officers would deploy 
with Narcan.  The general sentiment from the dissenting public complained officers did 
not carry Epi-Pens or insulin for allergic reaction or diabetics.  Davis et al. (2015) noted 
some departments delayed equipping their officers with Narcan/naloxone due to liability 
concerns.  Fisher et al. (2016) concluded there are no significant adverse effects or 
outcomes with police deployment.   
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It is important to note; one participant was very concerned about junior officers' 
desire to use Narcan, which is leading to concern for their safety.  He stated multiple 
times junior officers are seemingly so eager to deploy the Narcan, they ignore officer 
safety protocols and try to get to the overdose scene as quickly as possible.  With this in 
mind, there is the potential of a role shift as junior/newer officers are learning the job 
with Narcan as a tool early in their career.  The Narcan element was not part of the senior 
officer's early training; the focus was strictly police policy and procedure. 
Frustration 
At some point during each interview, the participating officers conveyed some 
measure of frustration with repeat users and those resistant to medical treatment after an 
overdose.  One participating officer expressed frustration with the community's lack of 
support, stating there was no counselor to call to talk to the individual after an overdose.  
Another officer stated some users seem to rely on the fact they can count on the police to 
respond with Narcan if they overdose.  Haug et al. (2016) noted some who oppose 
Narcan/naloxone use are fearful that widespread availability will lead to a false sense of 
security for the user.  One officer noted, if he was strictly a civilian, he would never give 
Narcan to someone due to potential liability. 
In many of the other studies, many of the participants noted the cost of 
Narcan/naloxone.  The only time any of the twelve participants mentioned the cost was to 
note it should not be a concern due to the availability of grants.  One participant stated, in 
his department they rarely use the Narcan, it is replaced because it expires more often 
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than not.  However, all the frustration presented by the participating officers seemed to 
stem from a desire to do more. 
Limitations of the Study 
Study limitations are facets of research that are uncontrollable and have the 
potential to negatively affect the study outcomes (Simon & Goes, 2013).  There were 
limitations of this study that must be mentioned.  First and foremost is the number of 
participants.  The study included only twelve law enforcement officers.  Also, the number 
of years' experience and the familiarity with Narcan/naloxone varied among participants.  
Additionally, due to the importance of using individuals who have experience using 
Narcan/naloxone as well as officers who have responded to an opioid overdose, I did not 
receive a large response to my participation requests.  Unfortunately, there were only two 
female and three minority participants; because of the small sample of willing 
participants, there was limited diversity.  The sample consisted of seven White males, 
two White females, two Latino males, and one African-American male. 
With all qualitative studies, the data collection process is solely dependent on the 
trustfulness, candor, and willingness to share personal beliefs of each participant.  These 
concerns were address by allowing each participant to not answer any question or 
discontinue the interview at their discretion without exception.  I hoped this would 
prevent the participant from including false information or feeling pressured to answer 
questions.  Additionally, I tried to maintain a conversational rapport with the interviewee 
and cultivate an environment suitable for free information sharing. 
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A final limitation of the study is the potential for research bias.  As the sole 
researcher, data collector, and analyzer, it is possible I developed preconceived opinions 
prior to the data collection phase.  Being aware of this potential issue, I made a conscious 
effort to review the data with an open mind and free from pre-conceptions.  I used otter.ie 
for transcription and did a manual review for corrections.  Going into the study, the plan 
was to use NVivo software to assist with coding.  Due to the small number of 
participants, I felt comfortable with completing descriptive coding manually. 
Recommendations 
Primarily, this study's results only focus on a small number of law enforcement 
officers from Jefferson County, Alabama.  Although there is a significant number of 
officers available, conducting a study with a larger number of participants will hopefully 
achieve a significant level of diversity.  Additionally, when asking questions related to 
the department's harm reduction policies, with the exception of the patrol supervisor, the 
officers did not seem confident in their understanding or familiarity with the policy.  
Seemingly, the policy can be socialized more to the junior officers or included as part of 
Narcan training.   
This study can add to the understanding of the important role law enforcement 
officers play in combating opioid overdose deaths, along with the number of people who 
have the opportunity to go to rehab in the wake of an overdose.  A similar study can aid 
in the understanding of additional resources needed to support law enforcement officers' 




This study can help create positive social change by bringing about awareness of 
law enforcement officers' concerns regarding their actions to save lives.  The law 
enforcement officers had an opportunity to express their thoughts, concerns, and feelings 
regarding their involvement in harm reduction.  From the police department's point of 
view, this study could provide awareness to supervisors, leadership, and other 
policymakers.  From the community standpoint, awareness from this study could provide 
a more positive light on the deployment of Narcan by law enforcement officers and their 
efforts to help combat the opioid epidemic.   
Employing personal interviews as the methodology of this study allowed each 
participant to be open and honest regarding their feelings towards the topic.  The 
interview questions brought awareness and allowed the participants to acknowledge 
aspects of their mental wellbeing that may not be considered or addressed.  
Conclusion 
This qualitative phenomenological study provided the lived experiences of law 
enforcement officers and their roles during an opioid overdose.  Conclusions based on the 
study findings include a deep-seated duty to serve their community.  It is important to 
note an individual's social identity is not solely related to their parent group, but also the 
underlying in-groups (Ashforth & Mael, 2016; Heaven et al., 2013; Smith, 2016).  As it 
relates to this study, it can be concluded, the growing employment of Narcan is 
redefining the law enforcement community and thus creating a new in-group.  No matter 
the charge, these officers are committed to saving lives, even when facing life-threatening 
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hazards.  This is all accomplished while combatting daily frustrations.  Brown (2015) 
noted an individuals' identity could be defined by their future projected self.  Currently, 
the future projected self for law enforcement officers includes the employment of Narcan.  
This study focused on the motivation in becoming a law enforcement officer in order to 
understand their motivations.  Through the questions about law enforcement's family 
history, the officers painted a picture of their path into the career field.  
The values of the participants were also expressed through this research.  Each 
officer voluntarily completes the required training as well as equipping themselves with 
Narcan daily.  They view the responsibility as an honor, and though there is no 
requirement, they respond to overdose calls routinely.  Although work in the law 
enforcement career field is inherently dangerous, officers are increasing their risk by 
adopting the additional role during an opioid overdose episode.  The data of this study 
revealed there is no negative view of the new roles.  An individual's positive identity is 
associated with good self-esteem and strong resilience (Brown, 2015; Conroy & O'Leary-
Kelly, 2014; Lawson, 2014).  As law enforcement officers view their employment of 
Narcan as a positive act, Narcan employment is being adopted as part of the law 
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Appendix: Semistructured Interview Guide 
Introduction: 
Thank you for agreeing to participate in this interview.  We are conducting this interview 
to gain an understanding of how law enforcement officers feel about the harm reduction 
policy that requires you to carry and employ Narcan/naloxone during an opioid crisis. 
Your participation in this study is voluntary and your decision to participate or not 
participate will not affect you in any way.  You are not obligated to answer any of the 
questions asked and may terminate the interview at any time.  This interview should take 
approximately one hour depending on how much information you would like to share.   
 
With your permission I would like to record this interview, so I do not miss out on any of 
your valuable comments. 
 
All responses will be kept confidential, meaning your de-identified interview responses 
will only be shared with my research team members and we will ensure any information 
included in our report does not identify you as the respondent.  You may decline to 
answer any question or stop the interview at any time, for any reason.  Do you have any 
questions? 
 
May I turn on the recorder? 
 
Research Question:  
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How do law enforcement officers, who are mandated by policy to carry and administer 




Before we begin, please tell me a little about yourself.   
How did you end up in Alabama? 
Alabama or Auburn? 
Are you married? 
Any children? (Boy/Girl/Age)  
How does your family feel about you being in law enforcement? 
What lead you into the Law Enforcement career field? 
How long have you been in law enforcement? 
Tell me about any friends or family members who were in Law Enforcement 
before you joined. 
What do you enjoy most about being a law enforcement officer? 
Now that you have been in law enforcement for this long,  
How similar is the job then you imagined? 
How different is the job then you imagined? 
Tell me about the area you normal patrol. 
How would you describe your patrol area? 
Tell me about the inhabitants of your patrol area. 
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What is the training and certification requirements for your assigned weapons? 
How much additional equipment are you required to carry on duty? 
How much equipment is on your duty belt? 
How does the requirement to carry Narcan/naloxone apply to your duty 
equipment? 
What is the process in your department for officers to carry Narcan/naloxone? 
How long have you been carrying Narcan/naloxone? 
Tell me about the training or certification requirement to carry and administer 
Narcan/naloxone. 
What are the requirement per shift, to carry Narcan/naloxone? 
What are your thoughts on the requirement to carry Narcan/naloxone? 
What are your thoughts on the requirement for law enforcement officers to carry and 
administer Narcan/naloxone as a law enforcement officer’s typical duties? 
What do you feel is your role when interacting with illegal drug users? 
Tell me how your expected role aligns with the harm reduction policy? 
What is a typical response if you suspect an individual is in possession of illegal drugs? 
Tell me how your expected response aligns with the harm reduction policy? 
What reservation do you have about administering Narcan/naloxone? 
How often have you had to administer Narcan/naloxone in the line of duty? 
Tell me what affects does carrying Narcan/naloxone have on your ability to focus on your 
duties? 
How did the individual react when you administered Narcan/naloxone? 
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How would you describe the procedure of administering Narcan/naloxone? 
What is the difference between law enforcement and medical personnel when 
administering Narcan/naloxone? 
Tell me any fears or concerns you have of public backlash if something were to go wrong 
after administering Narcan/naloxone. 
 
This concludes my interview questions; would you like to add anything or make any type 
of statement to be included in your interview? 
 
Is there a question I should ask on my next interview? 
 
Thank you for your time and candor, once I complete the report on our discussion I will 
email you a copy for your review.  If you find anything in the report misrepresents your 
intentions, please provide that feedback. 
 
Again, thank you. 
 
